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Abstract 
Brain structural abnormalities as well as neurocognitive dysfunction, are found in 
schizophrenia and in bipolar disorder. Based on the fact that both brain structure and 
neurocognitive functioning are significantly heritable and affected in both 
schizophrenia and bipolar disorder, relationships between them are expected. 
However, previous studies report inconsistent findings. Also, schizophrenia and 
bipolar disorder are classified as separate disease entities, but demonstrate overlap 
with regard to symptomatology and genetic liability. Few studies have directly 
compared brain structure abnormalities or relationships between brain structure and 
neurocognitive functioning between the diseases and, it remains unclear if findings are 
similar or different between patients with schizophrenia or bipolar disorder. The aims 
of the thesis were 1) to characterize brain structure and the relationships with 
neurocognitive performance in schizophrenia and bipolar disorder and healthy control 
subjects and, 2) to investigate these characteristics for differences and similarities 
between the subject groups.  
Two independent subject samples from two similar ongoing research projects at 
Karolinska Institutet in Sweden (HUBIN) and at the University of Oslo in Norway 
(TOP), were included. The participants were patients with schizophrenia or bipolar 
disorder, and healthy control subjects. All subjects were characterized using magnetic 
resonance imaging (MRI) of the brain and neuropsychological test methods. Brain 
cortical thickness and surface area measurements, as well as subcortical structure 
volumes were obtained using automated computer image analysis methods.  
Schizophrenia and bipolar disorder type 1 patients demonstrated cortical thinning in 
overlapping prefrontal and temporo-parietal brain regions compared with healthy 
controls, and schizophrenia and bipolar disorder patients demonstrated similar 
findings of subcortical volume abnormalities, compared to healthy controls. The 
identified abnormalities were more pronounced among schizophrenia patients. 
Cortical thickness and surface area in predominantly frontal and temporal regions, but 
also occipital regions, and several of the subcortical structure volumes, were related to 
neurocognitive performance in both patients and healthy controls. Between-group 
comparisons showed that some structure/function relationships were specific to 
schizophrenia and/or bipolar disorder.  
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In conclusion, the results demonstrate numerous similar brain structure abnormalities 
in schizophrenia and bipolar disorder, consistent with a common underlying 
pathophysiology. Mostly similar brain structure/function relationships were found 
between patients and controls. Few relationships were found to be similar in 
schizophrenia and bipolar disorder, but different from healthy controls. Consequently, 
our findings do not indicate that the neurocognitive dysfunction found in both 
schizophrenia and bipolar disorder have common brain structural correlates. Some 
disease-specific relationships were found between brain structure and neurocognition, 
possibly reflecting disruptions in brain regions that contribute to specific cognitive 
functions and, could be of relevance to the pathophysiology in schizophrenia and 
bipolar disorder. 
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1. Introduction 
Schizophrenia and bipolar spectrum disorders are severe mental illnesses. Both 
disorders are ranked among the top ten diseases as leading causes of disability on the 
WHO global burden of disease report (1998). Schizophrenia was first described as 
Dementia Praecox by the German psychiatrist Emil Kraepelin in 1899 (Kraepelin, 
1917). Kraepelin suggested dementia praecox was different from manic-depressive 
insanity, later known as mood disorders. According to Kraepelin, Dementia Praecox 
was characterized by early onset of disease with subsequent cognitive deterioration 
and poor outcome, while manic-depressive disorder was characterized by episodicity 
and better outcome. Since then the clinical picture, rather than aetiology or pathology 
defined the disorders. In 1911, the Swiss psychiatrist Bleuler introduced the term 
schizophrenia (Bleuler, 1950), while the German psychiatrist Karl Leonhard was the 
first to introduce the term bipolar disorder in 1957 (Goodwin et al., 2007). Although 
the distinction between the two disorders has been under long time debate, 
schizophrenia and bipolar disorder are still categorized as separate disease entities 
defined by symptoms, in the current diagnostic systems, DSM-IV (First, 2002) and ICD-
10 (World Health Organization, 1993). The diagnostic criteria in the diagnostic 
systems are important both for clinical work as well as scientific psychiatric research 
as they provide common nomenclature and increase objectivity and precision. The 
debate on disease classification has once again been intensified by the upcoming DSM-
V and ICD-11 editions, based on the fact that the disorders have, to some extent, 
overlapping heredity, pathophysiology, clinical features and cognitive dysfunction.  
When this thesis was planned, the two disorders had mainly been studied separately, 
and the current knowledge on differences and similarities between them was based on 
comparisons across different methodologies. Few scientific studies had directly 
compared schizophrenia and bipolar disorder. The main focus in this thesis was the 
pathophysiological characteristics, i.e. brain structure, and the relationship with 
cognitive dysfunction, in schizophrenia and bipolar disorder, and the similarities and 
differences between the disorders. Since the disorders are defined as separate 
diagnostic entities based on symptoms and clinical course, these areas are introduced 
separately for the two disorders, whereas other aspects such as neurocognitive 
functioning, aetiology, neurobiology and brain structure abnormalities are presented 
together with a focus on shared and unique features. In general, schizophrenia has 
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been more studied in biological psychiatry than bipolar disorder. Consequently the 
bulk of studies that are cited are skewed towards schizophrenia.  
1.1 Schizophrenia spectrum disorders 
Definition 
The schizophrenia spectrum disorder group consists of several subtypes (Appendix 1). 
For the present thesis schizophrenia, schizophreniform disorder and schizoaffective 
disorder were included and based on the DSM-IV criteria (American Psychiatric 
Association, 1994). The DSM-IV criteria for a diagnosis of schizophrenia include (1) 
presence of characteristic symptoms such as delusions, hallucinations, disorganized 
speech, grossly disorganized or catatonic behaviour, negative symptoms, i.e., affective 
flattening, alogia, or avolition. Two or more of the symptoms must have been present 
for one month. Only one symptom suffices if the delusions are bizarre or the 
hallucinations consist of a voice keeping up a running commentary on the person's 
behaviour or thoughts, or two or more voices converse with each other. (2) For a 
significant portion of the time since the onset of the disturbance, one or more major 
areas of functioning such as work, interpersonal relations or self-care are markedly 
below the level achieved prior to the onset. (3) Continuous signs of the disturbance 
persist for at least 6 months. This 6-month period must include at least 1 month of 
symptoms (as described above). In order for the schizophrenia criteria to be fulfilled, 
the symptoms should not be better accounted for by having schizoaffective disorder or 
mood disorder or be physiological effects of substance abuse or a medical condition. 
The relationship to pervasive developmental disorder should be considered.  
In schizophreniform disorder the signs of the disturbance have been present for more 
than one month, but less than six months, and functional decline need not be present. 
All other criteria described for schizophrenia must otherwise be met. In schizoaffective 
disorder, there is either a major depressive episode, manic episode or mixed episode 
concurrent with the characteristic symptoms in schizophrenia. Furthermore, during 
the same period of illness, there have been delusions or hallucinations for at least 2 
weeks in the absence of prominent mood symptoms. Symptoms that meet criteria for a 
mood episode are present for a substantial portion of the total duration of the active 
and residual periods of the illness. 
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In the following these three subtypes will collectively be referred to as 
“schizophrenia”. 
Prevalence 
Based on systematic reviews, schizophrenia prevalence is estimated to be 0.5-1% 
(Saha et al., 2005), while incidence rates are 15 / 100000 and might vary according to 
gender, migration status, urbanicity and latitude (McGrath et al., 2008). A recent report 
from Denmark estimated the prevalence cumulative incidence to be 1.12% (Gottesman 
et al., 2010). The prevalence in Norway has been estimated to be 0.15% in Rogaland 
and 0.25% in Oslo in 1983 (Johannessen, 2002), and 0.4% in Oslo in a study from 2001 
(Kringlen et al., 2001). The annual costs directly or indirectly related to schizophrenia 
in Norway have been estimated to 4 billion kroner in 1995 (Rund, 1995). 
Clinical course, treatment and outcome 
Illness debut is typically in adolescence or early adulthood, although earlier or later 
debut is not infrequent. The onset of illness occurs 5-7 years later in women than in 
men. Prior to onset, a premorbid phase with cognitive and motor abnormalities and a 
prodromal phase with emerging positive symptoms and declining function are often 
present. Illness debut is defined by the first psychotic episode. In addition to the 
symptoms that define the disorder, other psychopathological dimensions exist, such as 
cognitive, mood and motor symptoms (Tandon et al., 2009). Several psychotic 
episodes with variable duration typically occur with partial or total remission in 
between.  
The disorder has predominantly been treated with antipsychotic medication during 
the last decades, supplemented by psychosocial therapy. Since the discovery that 
Chlorpromazine exerted antipsychotic effect through postsynaptic dopamine D2 
blockade in the brain, a range of antipsychotic agents were developed acting on the 
same receptors (typical antipsychotics). Later, in the 1990s, a second generation of 
antipsychotic medication was developed, exerting more unspecific monoamine 
receptor effects, including the dopamine, serotonin and noradrenaline receptors 
(atypical antipsychotics). Although treatment with antipsychotics (AP) have improved 
outcome in schizophrenia, mainly positive symptoms are attenuated. Negative 
symptoms and cognitive impairments are only improved to a small or moderate 
degree (Woodward et al., 2005). In addition to treatment with antipsychotic 
medication, psychosocial treatment and cognitive remediation programs have been 
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developed. Both have shown promising effects on negative symptoms and cognitive 
functioning (McGurk et al., 2007;Pilling et al., 2002).  
However, despite available treatment, the course of illness is heterogeneous, and both 
chronicity and recovery (6-17%) (Lauronen et al., 2005) may occur as the extreme 
outcomes of course progression. Statistically, patients with schizophrenia exhibit 
increased mortality (Brown, 1997), increased suicide risk (Barrett et al., 2010) and 
increased risk for co-morbid medical illnesses (Heiskanen et al., 2003) compared to 
the healthy population.  
1.2 Bipolar spectrum disorders 
Definition  
The bipolar spectrum disorder group also consists of several subtypes (Appendix 1). 
For the present thesis bipolar disorder type 1 and 2 were included and based on the 
DSM-IV criteria (American Psychiatric Association, 1994). The DSM-IV criteria for a 
diagnosis of bipolar disorder type 1 (BD I) include the occurrence of one or more manic 
episodes or mixed episodes, while for bipolar disorder type 2 (BD II) these include the 
occurrence of one or more major depressive episodes accompanied by at least one 
hypomanic episode. A major depressive episode is defined by specifically described 
symptoms that have been present during the same 2-week period and represent a 
change from previous functioning; at least one of the symptoms is either (1) depressed 
mood or (2) loss of interest or pleasure. Also, the symptoms cause distress or 
functional impairment, and are not better accounted for by bereavement. A manic or 
hypomanic episode is defined as a distinct period of abnormally and persistently 
elevated, expansive, or irritable mood, lasting at least 1 week or 4 days respectively, 
accompanied by specifically described symptoms. In mania, the severity of symptoms 
cause marked impairment in functioning or necessitate hospitalization to prevent 
harm to self or others or, there are psychotic features. In hypomania the episode is 
associated with change in functioning, and together with symptoms, these 
disturbances are observable by others. Unlike mania, no marked functional decline or 
psychotic features are present. In order to fulfil the criteria for a bipolar disorder, none 
of the mood episodes must be caused or be better accounted for by physiological 
effects of substance abuse or a medical condition.  
In the following bipolar disorder type 1 and 2 will collectively be referred to as 
“bipolar disorder”. 
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Prevalence 
The lifetime prevalence of bipolar disorder is 1% for BD I and 1-2% for BD II (Goodwin 
et al., 2007). The prevalence of BD is usually stated to be relatively consistent across 
cultures and regions. However, prevalence rates vary from 0.1 - 1.8% for BD I, and 0.3 - 
3.0% for BD II (Angst, 1998;Sherazi et al., 2006;Weissman et al., 1996). In the Danish 
study by Gottesman et al. (2010) rates were estimated to be 0.63%. A Norwegian study 
reported life time prevalence to be 1.6% in Oslo (Kringlen et al., 2001).  
Clinical course, treatment and outcome 
Illness debut for bipolar disorder is typically in young adulthood (Goodwin et al., 
2007;Larsson et al., 2010). During the course of illness, patients with bipolar disorder 
experience multiple affective episodes, the depressive episodes being longer than the 
manic episodes. Furthermore, there are sub-syndromal affective symptoms (Joffe et al., 
2004) and cognitive impairment between episodes (Bora et al., 2009). But, as in 
schizophrenia, the individual illness course is variable with respect to frequency and 
duration of illness episodes (Salvatore et al., 2007). Symptoms are treated with mood-
stabilizing medication, such as lithium, antiepileptics or atypical antipsychotics. 
Medication treatment is used for prevention of new episodes. However, 75% still 
relapse during the first five years (Gitlin et al., 1995). Adjuvant psychotherapy, such as 
psychoeducative treatment has proven helpful (Colom et al., 2003).  
Bipolar patients may recover or as in schizophrenia exhibit a chronic course. 
Psychosocial functioning is often impaired even when full recovery is sustained 
(Coryell et al., 1993), and there is increased risk for co-morbid somatic disorders, 
suicide increased mortality rates (Khalsa et al., 2008) and shorter life span (McIntyre 
et al., 2007;Osby et al., 2001).  
1.3 Neurocognitive functioning in schizophrenia and bipolar disorder 
Neuropsychological tests are specifically designed tasks used to measure cognitive 
function in clinical groups. Neurocognitive functioning is a relatively new term used in 
research to describe cognitive functions presumably linked to the function of 
particular brain areas, neural pathways, or cortical networks in the brain. The terms 
cognitive and neurocognitive will be used interchangeably in the following. 
Cognitive decline in schizophrenia was described by Kraepelin but defied by Bleuler. 
Bleuler proposed that cognitive symptoms were subordinate of other symptoms and 
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the absence of cognition in the current diagnostic disease criteria reflect these views. 
Later however, general intellectual deficits in chronic schizophrenia were 
demonstrated by Johnstone et al. (1978), who also suggested that the cognitive 
dysfunction was primary and not secondary to institutionalization or symptoms of the 
disease. Since then, a growing interest in the field and acknowledgment of its 
importance has emerged. Reviews and meta-analyses report neurocognitive 
dysfunction with large effect sizes in schizophrenia across neurocognitive domains 
(Dickinson et al., 2007;Heinrichs and Zakzanis, 1998), and neurocognitive dysfunction 
seems to represent an independent feature of the disease, although associations with 
negative symptoms have been shown (Nieuwenstein et al., 2001). In general, the 
pattern of neurocognitive dysfunction in bipolar disorder is similar to the 
neurocognitive profile of schizophrenia (Barch, 2009). Although impairment may be 
somewhat state dependent in bipolar disorder (Kurtz and Gerraty, 2009), a number of 
recent meta-analyses have reported neurocognitive dysfunction in bipolar disorder 
patients in the euthymic phase (Bora et al., 2009;Robinson et al., 2006). So far 
dysfunction is found to be more pervasive in schizophrenia than in bipolar disorder 
(Heinrichs, 2005;Krabbendam et al., 2005), but cognitive dysfunction has been related 
to functional outcome in both disorders (Green, 2006). The first-degree relatives of 
schizophrenia and bipolar disorder patients show similar cognitive dysfunction; 
although the abnormalities are less salient, this finding supports the heritability of 
cognitive dysfunction (Bora et al., 2009;Snitz et al., 2006). In general, neurocognitive 
dysfunction in all domains remain stable over the course of schizophrenia (Kurtz, 
2005;Rund, 1998), whereas deficits in attention and executive function seem to be 
maintained over time in bipolar disorder (Burdick et al., 2006;Mur et al., 2008) and 
may even worsen as the disease progresses (Robinson and Ferrier, 2006). The effect of 
medication on neurocognition in schizophrenia and bipolar disorder is considered to 
be small to moderate (Balanza-Martinez et al., 2010;Mishara and Goldberg, 2004), but 
findings are inconclusive (Hill et al., 2010). In sum, neurocognitive dysfunction is 
consistently found in both schizophrenia and bipolar disorder and largely appears to 
be trait rather than state dependent. Furthermore, neurocognitive dysfunction is 
observed over the course of illness despite fluctuations in symptom severity and use of 
medication, and has been suggested to represent a core feature in both disorders. 
1.4 Aetiology and neurobiology 
The neurodevelopmental model has for several decades been posited and gained 
support as an explanatory model for schizophrenia. In this model, aberrations in 
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neurodevelopmental processes begin long before the onset of symptoms, and are 
caused by a combination of environmental and genetic factors (Murray and Lewis, 
1987;Weinberger, 1987). Putative neurodevelopmental factors in bipolar disorder are 
less studied and hence, are more uncertain (Murray et al., 2004;Sanches et al., 2008). 
Despite great scientific effort, no single cause or determining factor has been 
discovered in either schizophrenia or bipolar disorder, but specific genetic and 
environmental risk factors, and gene-environmental interactions have been proposed 
as results from research.  
1.4.1 Genetic risk factors 
Twin-studies and epidemiological studies have estimated heritability to be 60-80% in 
schizophrenia and bipolar disorder (Cardno et al., 1999;Lichtenstein et al., 
2009;Sullivan et al., 2003). Until recently, there was no evidence for the increased risk 
of one disorder among relatives of the other disorder (Berrettini, 2001), but the large-
scale epidemiological study by Lichtenstein et al. (2009) involving 9 million Swedish 
subjects suggested shared and distinct genetic liability for the two disorders. Linkage 
studies have proposed shared genetic susceptibility loci for schizophrenia and bipolar 
disorder, but findings are inconclusive (Berrettini, 2001). Association studies have 
proposed candidate genes in both disorders, such as G72/G30 (Chumakov et al., 
2002;Hattori et al., 2003;Maier et al., 2005), as has BDNF (Neves-Pereira et al., 
2002;Rosa et al., 2006), and the so-called zinc-finger gene, ZNF804A (Williams et al., 
2010). Similarly, the catechol-O-methyltransferase (COMT) gene which controls the 
breakdown of dopamine in the frontal cortex (Egan et al., 2001) has been reported to 
be weakly associated with schizophrenia (Kunugi et al., 1997;Shifman et al., 2002) and 
bipolar disorder (Shifman et al., 2004) and to modulate bipolar disorder, increasing 
the likelihood of rapid cycling (Kirov et al., 1998). Finally, rare copy number variants 
(CNVs) may account for some of the cases at least for schizophrenia (Stefansson et al., 
2008).  
1.4.2 Environmental risk factors 
Both schizophrenia and bipolar disorder have been associated with various 
environmental factors; substance misuse (Henquet et al., 2005;Henquet et al., 2006), 
prenatal factors (Brown et al., 2000;Susser et al., 1996), negative life events and 
childhood trauma (van Os et al., 1998). Others may be more specific for schizophrenia, 
such as advanced paternal age (Dalman and Allebeck, 2002), specific infectious 
diseases, notably winter/spring birth and urbanicity (Mortensen et al., 2003). 
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On the background of shared genetic liability different clinical manifestations in 
schizophrenia and bipolar disorder might be due to different environmental influences 
on the same or a single genotype (Benes, 2007) or additional genes (for example, 
genes involved in neurodevelopment) may then act, or interact, upon this background. 
1.4.3 Neurobiological findings  
In addition to the clinical characteristics that define the diseases, both schizophrenia 
and bipolar disorder are characterized by neurobiological abnormalities. 
Neurobiological studies have revealed neurotransmittor abnormalities, 
neurophysiological abnormalities, neuropathological alterations and structural and 
functional imaging abnormalities. In the following, topics that are relevant to the 
studies of the present thesis will be presented with an emphasis on brain structure 
abnormalities. 
Neurotransmittors 
Both dopamine and glutamate disturbances have been implicated in the 
pathophysiology in schizophrenia and bipolar disorder (Keshavan et al., 2008;Stone 
and Pilowsky, 2006). Both disorders are treated with dopaminergic D2 antagonistic 
drugs, which ameliorate positive psychotic and manic symptoms, while dopamine 
agonists may induce psychotic symptoms. Also, manipulation of dopamine D1 
receptors have been found to affect cognitive functions known to be impaired in 
schizophrenia and bipolar disorder, i.e., working memory (Abi-Dargham et al., 2002). 
It was recently proposed that schizophrenia was characterized by striatal 
hyperdopaminergic and prefrontal hypodopaminergic levels (Howes and Kapur, 
2009). The dopamine mechanism in bipolar disorder has been less investigated, but 
region-specific increase in dopamine activity may account for some parts of the 
pathophysiology (Cousins et al., 2009).  
Glutamate involvement is suggested based on the fact that NMDA receptor antagonists 
such as ketamine produce psychotic and cognitive symptoms resembling those found 
in schizophrenia (Moghaddam, 2003). Furthermore, genetic studies in both 
schizophrenia and bipolar disorder have implicated glutamate receptor genes (GRIN1, 
GRIN2A, GRIN2B and GRIK3), metabotropic glutamate receptor genes (such as GRM3), 
the G72/G30 locus and GABAergic genes (e.g. GAD1 and GABRB2) to varying degrees 
(Cherlyn et al., 2010). Research to develop glutamate-related antipsychotic medication 
has been initiated, but the results from this research have thus far not proven to be 
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effective.  
In addition to dopamine and glutamate, other neurotransmitters, such as serotonin, 
acetylcholine and adrenaline have been implicated in severe mental diseases. 
1.5 Neuroimaging 
Neuroimaging methods include a variety of techniques that all image the structure or 
function of the brain in vivo. Imaging of brain structure was originally made available 
from x-ray images. These provided an image of the ventricular system of the brain, 
which had been directly or indirectly filled with air (pneumoencephalography) (Jacobi 
and Winkler, 1927). Computer Tomography (CT) was introduced in the 1970’s and 
allowed for non-invasive detailed visualization of brain anatomy. This method involves 
potentially harmful amounts of ionizing radiation, while magnetism is currently 
believed to be safe for humans. Magnetic resonance imaging (MRI) became available in 
the 1980’s and offered the advantages of allowing for excellent grey and white matter 
contrast resolution in cortical and subcortical regions, and it permitted imaging of 
structures not readily visible on CT, such as the cerebellum and certain temporal lobe 
structures, both of which are of interest in schizophrenia and bipolar disorder studies. 
Thus, MRI is the preferred neuroimaging technique for the study of brain grey and 
white matter abnormalities in severe mental diseases, as was the topic for this thesis.  
1.5.1 Magnetic Resonance Imaging 
The MRI method is based on the principle that different tissue types have different 
magnetic properties (Weishaupt et al., 2006). Some atomic nuclei, such as the 
hydrogen nucleus exhibit spin around their own axis. The hydrogen atom is abundant 
in body tissue as part of the water molecule (H2O) and fat (carbon, oxygen and 
hydrogen atoms). The spin of its solitary proton gives a relatively large magnetic 
moment. In a normal environment, the magnetic moments of these protons point in 
random direction. When placed in a magnetic field, the protons line up with the 
magnetic field called alignment, either parallel with, or in the opposite direction of, the 
main field. Most are aligned in a parallel manner. Thus the net magnetization vector is 
parallel to the external field. In addition to the proton’s spin around its own axis, the 
magnetic field causes a secondary spin, the recession, in a circular manner around the 
main field. The precession frequency or larmor (ω0) is the rate at which spins wobble 
when placed in a magnetic field.  
ω0 = B0 × λ 
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λ is constant and related to type of atomic nucleus. Thus the precession frequency is 
directly proportional to the strength of the magnetic field, B0, which is measured in the 
unit Tesla (T). By applying radiofrequency (RF) pulse at the same frequency as the 
precession frequency of the MR active hydrogen nuclei, resonance occurs; the 
hydrogen nuclei absorb energy applied at 900 from the RF (excitation) causing the net 
magnetization vector to change direction compared to the external field, which is 
called a flip angle. The net magnetic vector in transverse plane induces a voltage in a 
receiver coil situated in this plane. When the RF pulse is removed, the voltage 
amplitude induced in the receiver coil decreases and is called free induction decay, 
which is a detectable signal. Through spatial encoding the signal is digitized and stored 
in K space. The 2-dimensional image consists of pixels which have each been allocated 
signal intensity. When slice thickness is considered, the 3-dimensional voxels are 
produced. 
The resulting high and low signals result in different contrasts in the MR images, but 
can be controlled by extrinsic contrast parameters. Biological tissue features also 
contribute to signal intensity. Depending of which of these are emphasized in an MR 
sequence, the resulting images differ in their tissue-tissue contrast. On T1 weighted 
images, fatty tissue appears bright (high signal), whereas tissue containing a high 
proportion of water appear dark (low signal). T1 weighted images, which were used in 
the present studies, are best for depicting anatomy.  
1.5.2 MRI and image processing  
In order to obtain measures of brain structure from MRI scans (morphometry) 
different quantitative techniques are used. Most studies have used regions-of-interests 
(ROI) or computational morphometry approaches. In ROI analyses, discrete brain 
regions are obtained either by manual tracing on MRI scans or by semi-automated or 
automated processes. However, ROI methods are time-consuming and often limit the 
number of structures to be studied and, are subjected to bias. In computational 
morphometry, software programs automatically measure brain structure 
characteristics with a minimum of manual corrections, thus allowing for unbiased 
analyses of large datasets with high precision and whole-brain assessments. A widely 
used technique is voxel-based morphometry (VBM), which measures whole brain 
volumes on a voxel-by-voxel (commonly 1 mm3) basis (Ashburner and Friston, 2000). 
More recently, Diffusion-Tensor-Imaging (DTI) techniques have been developed that 
measure macroscopic structural integrity of white matter bundles in the brain (Agartz 
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et al., 2001). Functional MRI (fMRI), in addition to electrophysiological studies, MR 
spectroscopy, and PET/SPECT are used to measure brain function (Malhi and 
Lagopoulos, 2008). In fact, the BOLD (Blood-Oxygen-Level dependent) - fMRI method 
is currently a more widely used method for investigating neural correlates of 
neurocognitive function than structural MRI measurements. However, given the 
variability in brain structure and neurocognitive functioning both in healthy 
individuals and in subjects with psychiatric disorders, and the interrelationship 
between functional and structural measurements on MRI (Lu et al., 2009), structural 
MRI complement the results from functional MRI studies in order to achieve a better 
understanding of the neurobiological foundation for disease-related cognitive changes 
(Fjell and Walhovd, 2010). 
1.6 Brain structure 
1.6.1 Development  
During the first weeks of foetal life, the neural tube forms from the folding and fusion 
of the ectoderm (neurulation). The neural tube then folds into three primary brain 
vesicles, the most rostral part forms the telencephalon, which later forms into e.g. the 
cerebral cortex, hippocampus, amygdala, basal nuclei and lateral ventricles, and the 
diencephalon, which later forms into e.g. thalamus and the third ventricle. The most 
caudal part forms into the cerebellum and the brainstem (Brodal, 2007). Extensive 
neuronal proliferation begins on embryonal day 40 within the ventricular zone that 
lines the cerebral ventricles (Rakic, 1988). Depending on the neuroblasts position, they 
differentiate to either neuronal cell types or microglia, and then migrate out to form 
cortical laminae in an inside- and -out manner, meaning that deeper layers are formed 
before more superficial ones. Most neurons travel along radial glia cells that serve as 
paths to the final destination. By week 32, the developing cortex has a full adult 
complement of distinct vertical lamina. Some neurons originate and migrate from the 
basal ganglia. The neuronal migration continues until birth. Processes such as 
apoptosis (programmed cell death), synaptogenesis and myelination start before birth. 
Synaptogenesis ends by adolescence, while myelination ends in early adulthood. When 
the neurons have reached their final destination synapses (neuronal connections) start 
to form. The connections are under continuous refinement and modification forming 
later mature synaptic connections that are believed to underlie neural circuits. During 
childhood and adolescence, maturational pruning is observed as reduced synaptic 
density and reflect a selective elimination of weaker synaptic processes based on 
  
22 
 
experience and endogenic factors (Huttenlocher, 1979;McGlashan and Hoffman, 2000).  
According to the “radial unit hypothesis” (Rakic, 1988), neurons originating within 
individual proliferative units in the ventricular zone, form ontogenetic columns within 
specific cytoarchitectonic areas. It is hypothesized that cortical surface area reflect the 
number of columns within a given region, and results from the number of proliferative 
units within the ventricular zone, whereas cortical thickness reflects the number of 
neurons within each cortical column and results from the number of cell-divisions 
within each unit. Thus, cortical thickness and surface area are products of two well-
differentiated ontogenetic processes and the two parameters can therefore separately 
be affected by genetic defects or extrinsic factors (Rakic, 1988). One study on 
adolescent first-degree relatives of schizophrenia patients demonstrated reduction in 
surface area, along with only a slight increase in cortical thickness in a one-year follow-
up study, suggesting different neurodevelopmental trajectories (Prasad et al., 2010). 
As such, demonstrations of separate abnormalities in cortical thickness and surface 
area measures could depict more detailed deviations than cortical volume, which is the 
product of the two, from normal brain development. Furthermore, it is believed that 
humans have experienced the increase in cortical surface size in evolutionary response 
to demands in the cognitive requirements (Rushton and Ankney, 2009), supported by 
consistent reports of positive correlations between whole-brain size and measures of 
intelligence (Witelson et al., 2006). Thus, if schizophrenia, and bipolar disorder to 
some extent, are neurodevelopmental disorders in which disruption of higher 
cognitive functioning is a core feature, abnormalities in normal cortical surface 
development may play a role in the pathophysiology of the diseases and, hence show 
disrupted relationships with neurocognitive performance.  
1.6.2 Heritability  
Heritability has been shown to be substantial for brain structure volumes (Peper et al., 
2007;Wallace et al., 2006), with higher heritability scores for the deeper structures 
(ontogenetically earlier formed), and moderate heritability scores for the surface 
structures measured in volumes (Kaymaz and van Os, 2009). Heritability estimates for 
cortical thickness are significant but vary according to brain regions (Kremen et al., 
2010;Rimol et al., 2010). Moreover, total and regional cortical thickness and surface 
area have been shown to be highly heritable in a twin study, but were essentially 
unrelated genetically (Panizzon et al., 2009), suggesting different genetic sources of 
influence. Interestingly, in a study of schizophrenia and bipolar probands and their 
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unaffected relatives (McIntosh et al., 2006), genetic liability to schizophrenia was 
related to brain structure abnormalities, which was not the case for bipolar disorder.  
1.7 Brain structure abnormalities in schizophrenia and bipolar disorder 
1.7.1 MRI studies 
In view of the fact that anatomical MRI is the topic of the present thesis, the following 
neuroimaging overview is restricted to sMRI studies (based on search in Pubmed until 
March 2010). 
Global brain volume and cortical regions 
Global brain volume reduction has been estimated to 2-4% in schizophrenia (Steen et 
al., 2006;Wright et al., 2000), while results in bipolar disorder are more 
heterogeneous. One meta-analysis by Hoge et al. (1999) did not find whole brain 
volume loss in bipolar disorder supported by negative findings in a meta-analysis on 
first-episode subjects (Vita et al., 2009). However, a more recent meta-analysis 
reported a small, but significant whole-brain reduction in bipolar disorder (Arnone et 
al., 2009). In addition to reduced whole brain volumes, regional grey matter reductions 
have been demonstrated in both disorders (Arnone et al., 2009), but the reductions in 
schizophrenia appear more extensive both in pattern and magnitude compared with 
bipolar disorder. In schizophrenia, the most consistently reported volume reductions 
are in the superior temporal gyrus and the medial temporal regions (Honea et al., 
2005), bilateral insula and anterior cingulate (Ellison-Wright et al., 2008;Fornito et al., 
2009b), while for bipolar disorder left anterior cingulate and right insula reductions 
have been implicated across studies (Bora et al., 2010).  
Although the meta-analyses suggest temporal lobe abnormalities to be specific to 
schizophrenia, studies that have made direct comparisons of cortical structure 
between schizophrenia and bipolar subjects have demonstrated similarities in 
temporal lobe volumes (Kasai et al., 2003b;Pearlson et al., 1997). However, these are 
few and limited by small sample sizes (Farrow et al., 2005;Lim et al., 1999), and have 
mainly investigated specific regions (Altshuler et al., 2000;Nakamura et al., 2007;Rossi 
et al., 1991). Two VBM studies have included both schizophrenia and bipolar disorder 
patients. McIntosh et al. (2004) found reduced middle frontal gyrus volume specifically 
in schizophrenia. However, this study did not directly compare between patient 
groups, but only reported comparisons with the healthy control group. A second study 
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(Morgan et al., 2007), compared cortical volumes in first-episode patients with 
schizophrenia and affective psychosis (including depressive psychosis) and found 
smaller bilateral anterior cingulate volumes in the affective psychosis group, compared 
with the schizophrenia group. However, the results in the affective psychosis group did 
not remain significant when antipsychotic medication was statistically controlled for. 
Thus, it remains elusive whether the observed brain volume abnormalities in 
schizophrenia and bipolar disorder are specific to either disorder.  
Cortical thickness studies have demonstrated thinning in predominantly frontal and 
temporal regions in schizophrenia, although regional parietal and occipital thinning 
has also been found (Goldman et al., 2009;Kuperberg et al., 2003;Nesvag et al., 2008). 
Regional cortical surface area has been shown to be reduced in first-episode 
schizophrenia (FES) patients (Gutierrez-Galve et al., 2010) and in drug-naïve 
schizophrenia subjects (Crespo-Facorro et al., 2000), relative to healthy controls. The 
latter study demonstrated surface reduction without cortical volume differences, 
suggesting that surface based methods may be more sensitive to subtle cortical 
abnormalities than volumetric methods.  
Only one study has explored whole-brain cortical thickness in bipolar disorder (Lyoo 
et al., 2006), and reported scattered regional thinning in frontal, temporal, parietal and 
occipital regions in bipolar disorder subjects, as compared with healthy controls. Other 
studies have examined cortical thickness in ROIs and reported cortical thinning in 
paracingulate regions (Fornito et al., 2008) and increased thickness in right anterior 
cingulate (Fornito et al., 2009c) in bipolar I disorder.  
Subcortical regions 
Ventricular enlargements are the most consistent findings common to both 
schizophrenia (Shenton et al., 2001), and bipolar disorder (Kempton et al., 
2008;McDonald et al., 2004), with more extensive enlargements in schizophrenia. 
Enlarged striatal structures are also reported in both disorders (Brandt and Bonelli, 
2008;Strakowski et al., 2005). However, the observed abnormalities may be 
confounded by use of antipsychotic medication (Navari and Dazzan, 2009). Reviews 
report hippocampal (Steen et al., 2006), amygdala (Shenton et al., 2001) and thalamic 
(Ellison-Wright and Bullmore, 2010) volume reductions to be consistent in 
schizophrenia, but not in bipolar disorder (Ellison-Wright and Bullmore, 2010), 
compared with healthy controls. One study that directly compared schizophrenia and 
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bipolar patients found smaller hippocampus in schizophrenia and larger amygdala in 
bipolar disorder (Altshuler et al., 2000). A specific focus on amygdala as an important 
brain structure in the neurobiology of bipolar disorder has not yielded consistent 
findings (Brambilla et al., 2008), which may be due to differences in age and lithium-
use across studies (Usher et al., 2010a;Usher et al., 2010b). 
There are reports of progressive ventricular enlargements (DeLisi et al., 
2004;Kempton et al., 2010) and reductions in frontal (Zipparo et al., 2008) and 
temporal grey matter volumes (Hulshoff Pol and Kahn, 2008) in schizophrenia. 
Ventricular enlargement progression appears to continue in chronic stages (Kempton 
et al., 2010), while grey matter reductions may be more pronounced the first few years 
after disease onset (Kasai et al., 2003a;Yoshida et al., 2009). The study by Kasai et al., 
found no progression in the early phases of affective disorder, and suggested 
progression to be specific to schizophrenia. However, progressive grey matter 
reductions in BD I patients have been demonstrated by others (Moorhead et al., 2007) 
and has been related to number of affective episodes (Strakowski et al., 2005).  
1.7.2 Neuropathological post-mortem findings  
The evidence from macroscopic post-mortem studies is largely consistent with in vivo 
MRI studies of patients with schizophrenia; reduced total brain volume, increased 
ventricular volumes and reduced size of temporal lobe and subcortical structure 
volumes have been found (Harrison, 1999), although not consistently. Of greater 
interest, however, are the microscopic findings that are undetectable with the current 
MRI scan resolution. Histological studies have not found overall neuron loss or gliosis 
(as signs of injury) in the brains of schizophrenia patients, in contrast with the findings 
in neurodegenerative disorders, and are consequently taken as support for the 
neurodevelopmental model of schizophrenia. Reductions in neuronal size and 
neuronal arborisation, and increased neuronal density in Brodmann areas 9 and 46 in 
the frontal lobe are reported, as well as trends for reduced cortical thickness (Selemon 
et al., 1995;Selemon et al., 1998). Interestingly, specific reductions of one layer (V) has 
been found, from which neuronal efferents project to subcortical structures (Brodal, 
2007), possibly affecting communication with grey matter structures deeper within 
the brain. The observed cortical grey matter loss in schizophrenia has been proposed 
to be due to loss of neuropil, i.e., reduced glial cells and synaptic and dendritic arbors 
and reduced vascularization, as a result of exacerbated pruning during adolescence.  
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Similarly, reductions in neuronal size have been demonstrated in frontal brain regions 
in bipolar disorder. However, these findings are accompanied by a decrease in cortical 
density (Harrison, 2002), suggesting cytoarchitectural differences between 
schizophrenia and bipolar disorder (Rajkowska et al., 2001).  
In summary, structural brain abnormalities are to a certain extent overlapping in 
schizophrenia and bipolar disorder, but appear more pronounced in schizophrenia 
than in bipolar disorder. However, compared to schizophrenia, structural brain 
abnormalities in bipolar disorder are less studied and the existing studies are possibly 
underpowered to detect the subtle abnormalities that may be present. Also, few direct 
comparisons have been made. Thus, larger studies that include both patient groups 
and directly compare between groups that are investigated with the same 
methodology are essential. The previous literature furthermore suggests that BD I 
patients may demonstrate similar abnormalities to schizophrenia patients, and that 
some brain abnormalities progress with age or illness duration. Therefore, separate 
analyses of within-spectrum subgroups, and individual differences in age and illness 
duration should be considered. 
1.8 Brain structure relationships with neurocognitive functioning in 
schizophrenia and bipolar disorder 
The idea that different brain functions are localized to discrete regions of the brain 
was originally described in 19th century by Gall and Spurzheim, who developed 
theories of phrenology (Gall and Spurzheim, 1808). Supporting the separation of brain 
functioning, Broca (1861) and Wernicke (1874) later discovered localized regions 
involved in language formation and comprehension through lesion studies on subjects 
with language difficulties, while around 1875, Hughlings Jackson proposed 
topographic representation of the cerebral cortex based on his studies on the 
complexity of epileptic seizures (Taylor, 1932). In contrast, Flourens did lesional work 
in animals, and found that any lesion anywhere produced altered behaviour consistent 
with the theory that general structure integrity or brain networks underlie cognitive 
function (Flourens, 1846). Today´s cortical regional classification is partly based on 
cytoarchitectonic differences, that is, regional differences in cellular organization first 
described by Brodmann (Brodmann, 1909). Later scientific work has shown that 
integrity of both general and specific brain structures is important for brain function. 
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1.8.1 Theoretical relationships  
The notion that regional or localized structural deficits or abnormalities may relate to 
the cognitive dysfunction observed in schizophrenia and bipolar disorder may seem 
over-simplistic. However, specific relationships are hypothetically expected based on 
the following assumptions: 1) that brain tissue is altered in size in severe mental 
illness, 2) that neurocognitive functioning is impaired in severe mental illness and, 3) 
that neurocognitive functioning requires intact brain structures. The assumptions 1) 
and 2) were considered in the above sections and are present in schizophrenia and 
bipolar disorder. With regard to the third assumption, previous studies have 
demonstrated positive relationships between neurocognitive functions and regional 
brain structure as measured as cortical thickness in MRI-based studies of healthy 
adults (Dickerson et al., 2008;Fornito et al., 2004;Narr et al., 2007;Walhovd et al., 
2006), as well as dysfunction in individuals with focal brain lesions (Stuss et al., 
2001a;Stuss et al., 2001b). These findings suggest that regional brain structure 
integrity is important for cognitive performance, and that individual differences in 
regional brain structure measures, account for considerable variance in individual 
differences in neurocognitive functioning (Haier et al., 2004). Several theories have 
been introduced to explain how regional or discrete brain structures contribute to 
cognitive function in general, and how regionally constrained brain abnormalities, may 
lead to dysfunction in severe mental illnesses.  
Separate brain regions are engaged in forming networks. Brain studies on animals 
have mapped structures that are anatomically connected to form parallel networks 
that underlie cognitive functioning (Goldman-Rakic, 1988). Furthermore, these 
networks form patterns of structural connections where specific regions or structures 
may function as nodes, or play a central role in specific cognitive functioning. The 
different nodes communicate through network activity, and may thus overlap with 
functional networks (Haier et al., 2004;Lu et al., 2009). It is not known whether these 
patterns or networks are stable or have high plasticity, but changes have been 
observed related to disease, ageing or experience, suggesting that communications 
may be altered.  
In support of disrupted network communication in diseases, neuropathological studies 
have reported reduced neuronal arborization (Selemon and Goldman-Rakic, 1999), 
reduced synaptic function (McGlashan and Hoffman, 2000) and reduced connectivity 
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in distal dendritic processes (Kalus et al., 2000) in the presence of preserved neuron 
number in schizophrenia.  
Similarly, Friston and Frith (1995) proposed that abnormal integration of 
physiological processes in diverse cortical regions lead to disrupted connectivity 
(“disconnectivity”), that in turn results in cognitive dysfunction in schizophrenia. 
Indeed, disrupted connectivity in schizophrenia and bipolar disorder has been 
demonstrated in fMRI studies (Wolf et al., 2007) or DTI studies (Ellison-Wright and 
Bullmore, 2009;Kyriakopoulos and Frangou, 2009;Mahon et al., 2010;White et al., 
2007). Furthermore, one DTI study (Nestor et al., 2004) showed that neurocognitive 
functioning was correlated with impaired connectivity in schizophrenia patients, but 
not in healthy controls. Andreasen et al. (1998) extended the disconnectivity 
hypothesis to involve subcortical structures, and suggested that “Cognitive Dysmetria” 
or poor mental coordination resulted from disrupted connectivity between frontal 
lobe regions, thalamic nuclei and the cerebellum. Whereas Weinberger et al. (1992) 
proposed that fronto-temporolimbic (including the hippocampus) network 
dysfunction was related to cognitive dysfunction in schizophrenia. There is also 
evidence that other subcortical structures, such as the basal ganglia play a modulatory 
role in cognitive functioning (Graybiel, 2000;Simpson et al., 2010), and that “cognitive 
disorganization” in both mania and schizophrenia results from disruptions in 
prefronto-striato-pallido-thalamo-cortical loops.  
Five separate loops or closed circuits appear to exist (Alexander et al., 1986), of which 
three involve non-motor cortical regions originating in the frontal cortical lobe, and all 
three are thought to be involved in cognitive processes.1  
Although the loops are separate and organized in a parallel manner, there is a 
convergence of information at several levels. Hypothetically, structural deficits in any 
part of the circuits may affect cognition.  
                                                        
1 1) The dorsolateral prefrontal circuit originates from the cortical regions corresponding to Brodmann area 9 and 
10. Neuronal connections project to caudatus nucleus, and then via substantia nigra to thalamus, then back to the 
originating cortical regions. The dorsolateral prefrontal circuit allows for organization of goal directed behaviour 
and has been linked with executive function. 2) The anterior cingulate circuit originates in the Brodmann area 24. 
Neurons project to caudate, putamen, nucleus accumbens and the olfactory tubercle, then via pallidum and 
substantia nigra, and then to thalamus, before projecting back to the anterior cingulate. The anterior cingulate 
circuit has been linked to apathetic behaviour. 3) The orbitofrontal circuit originates in the Brodmann regions 10, 
11 and 47. Neurons projects to the caudate, via the pallidum and substantia nigra to thalamus and back to the same 
region. This circuit has been found to integrate limbic and emotional information into behaviour.  
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1.8.2 Empirical relationships 
Kraepelin proposed that the observed cognitive dysfunction in dementia praecox was 
related to abnormal brain function, but at the time there were limited ways of 
investigating neural correlates of brain function. With the advent of neuroimaging in 
general, and MRI in particular, the possibility to investigate the relationship between 
brain structure and function was greatly facilitated. Johnstone et al. (1976;1978) 
demonstrated that enlarged ventricular size measured with CT was associated with 
intellectual impairment in chronic schizophrenia. Since the onset of MRI scanning in 
the 1980’s and 90’s, a large number of scientific studies have attempted to determine 
the relationships between brain structure and neurocognitive functioning in 
schizophrenia. Most studies have been ROI based and investigated regional volumes 
that were abnormal in schizophrenia as compared to healthy controls in order to 
investigate the clinical (or cognitive) significance of the structural abnormalities.  
Cortical regions  
Antonova et al. (2004) summarized the results from 35 ROI studies on schizophrenia 
published in the period from 1991 to 2005. This review reported regional frontal lobe 
volumes to be related to executive functioning, attention, verbal and visual memory in 
schizophrenia. Lateral regions of the temporal lobe were related to verbal abilities and 
executive functioning, while the medial temporal lobe structures were related to 
memory functions. There were some differences in relationship patterns between 
schizophrenia patients and healthy controls, which the authors in part related to 
gender differences. Among all studies in the review, only one study investigated 
posterior brain regions; Sullivan et al. (1996) included parietal and occipital lobe 
volumes when investigating relationships with several cognitive domains, and 
reported negative findings. Subsequent VBM studies have allowed for whole-brain 
analyses that are not restricted to predefined regions, and have reported highly 
localized relationships. VBM studies on schizophrenia patients have related larger 
precuneus volume to better verbal learning (Antonova et al., 2005), smaller 
orbitofrontal volume to poorer verbal learning (Matsui et al., 2008), smaller superior 
frontal (Bonilha et al., 2008), and dorsolateral prefrontal cortical and anterior 
cingulate volumes to poorer executive functioning (Rusch et al., 2007).  
In bipolar disorder, frontal lobe volumes have been related to general cognitive 
dysfunction (Coffman et al., 1990) and attention (Sax et al., 1999) in two ROI studies, 
but in general, there has been a paucity of studies on structure/function in bipolar 
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disorder (Bearden et al., 2001). More recently, one VBM study related lateral and 
medial temporal lobe structures as measured with magnetization transfer imaging, to 
estimated IQ decline (Bruno et al., 2006), while in an ROI study (Zimmerman et al., 
2006), relationships between anterior cingulate volumes and executive functioning in 
healthy controls subjects were found to be disrupted in bipolar disorder. A study that 
included both affective and schizophrenic first-episode psychosis patients 
(Minatogawa-Chang et al., 2009), found relationships between volumes of the left 
inferior frontal region and working memory in the schizophrenia group, but not in the 
affective psychosis group.  
Subcortical regions 
In schizophrenia, hippocampus and amygdala volumes (Goldberg et al., 1994;Gur et al., 
2000;Killgore et al., 2009), and cerebellar volumes (Toulopoulou et al., 2004) have 
been related to performance on memory tasks. Striatal (Mamah et al., 2007;Stratta et 
al., 1997) and thalamic volumes (Crespo-Facorro et al., 2007b) have been related to 
executive functioning and attention. Caudate volumes have been related to motor 
speed (Hokama et al., 1995). Ventricular size has been related to impaired flexibility 
and attention (Antonova et al., 2004), and executive functioning, visuomotor speed and 
verbal IQ (Lawyer et al., 2006). Only a few studies have addressed such relationships 
in bipolar disorder patients; hippocampal volumes have been related to measures of 
attention (Sax et al., 1999), verbal fluency and verbal working memory (Ali et al., 
2000), while others have reported negative findings (Haldane et al., 2008). In a direct 
comparison of patients with schizophrenia or bipolar disorder, Killgore et al. (2009) 
demonstrated opposite relationships between amygdala volumes and verbal memory 
performance between schizophrenia and bipolar disorder.  
1.9 Synopsis and introduction to aims 
To summarize the previous sections, the literature hitherto points to some similarities 
of brain structural abnormalities and of neurocognitive impairments across 
schizophrenia and bipolar disorder. However, there is also strong evidence for overall 
brain structural differences between the disorders as well as of greater neurocognitive 
impairment in schizophrenia than in bipolar disorder. Results from structure/function 
relationship studies have been inconsistent in schizophrenia. Based on findings in the 
previous literature, relationships between frontal lobe regions and executive 
functioning, and between medial temporal lobe regions and memory measures are 
expected in both schizophrenia and bipolar disorder. However, most studies have 
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focused on specific brain regions and associated these with performance on 
neurocognitive tests only from a limited number of domains within higher order 
cognitive functioning. Differences in methodology make it difficult to interpret the 
results, and the previous small sample sizes may not have had sufficient statistical 
power to detect the subtle relationships that are likely to be present. Given the 
proposed whole-brain networks underlying cognition, studies on brain structure and 
the relationships with neurocognition should include measurements encompassing the 
whole cortical mantle and most subcortical structures in order to adequately localize 
all relevant brain anatomical abnormalities, and be able to investigate the relative 
contribution of each structure to cognition dysfunction in schizophrenia and bipolar 
disorder. Also, methods that more closely reflect the cytoarchitectural properties of 
the cortex, such as cortical thickness or surface area may enhance our ability to 
investigate how structure and function are related/or disrupted in schizophrenia and 
bipolar disorder. Additionally, there is little knowledge about the possible specificity to 
either disorder. Results from direct comparisons of brain structure and the 
relationships with neurocognition in schizophrenia and bipolar disorder may aid in 
the efforts to better delineate the disease entities against each other and ultimately 
shed light on the pathophysiology of these diseases. 
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2. Aims  
The aim of the present thesis was to 1) characterize brain structure and the 
relationships with neurocognitive performance in schizophrenia and bipolar disorder 
and healthy control subjects and, 2) to investigate these characteristics for differences 
and similarities between subject groups. To accomplish these goals, we conducted the 
following four studies: 
Study I 
The aim was to identify relationships between brain cortical thickness and 
neurocognitive performance, and investigate for differences in relationships between 
chronic schizophrenia patients and healthy controls.  
Study II  
The aim was to compare brain cortical thickness and subcortical volumes between 
schizophrenia and bipolar disorder patients to assess for differences and similarities in 
brain structure. 
Study III 
The aim was to characterize relationships between brain cortical thickness and surface 
area and neurocognitive functioning in schizophrenia and bipolar disorder and healthy 
controls and, investigate whether the relationships were similar or different between 
the groups.  
Study IV 
The aim was to characterize relationships between subcortical brain volumes and 
neurocognitive functioning in schizophrenia and bipolar disorder and healthy controls 
and, investigate for differences and similarities between the groups.  
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3. Methods 
3.1 Subject material 
The participants included in this thesis included patients with schizophrenia or bipolar 
spectrum disorders and healthy controls recruited at two separate sites: 
Study I:  Patients with schizophrenia spectrum disorder and healthy controls as 
part of the Human Brain Informatics (HUBIN) study, Stockholm, Sweden. 
Study II-IV: Patients with schizophrenia or bipolar disorder spectrum disorders and 
healthy controls as part of the Thematically Organized Psychosis (TOP) research 
project, Oslo, Norway. 
All studies were cross-sectional and conducted in a naturalistic setting. Group 
comparisons were performed. Subject description for the two cohorts is provided 
separately in the following, while an overview of demographics and clinical data is 
given in Appendix 2.  
3.1.1 HUBIN 
The HUBIN project is an ongoing project starting in 1995 with longitudinal clinical, 
neurocognitive, genetic and MRI assessments of adult schizophrenia spectrum patients 
and healthy controls.  
For the present study, unrelated Caucasian subjects were included between 1999 and 
2003. All healthy controls and patients within the schizophrenia spectrum 
(schizophrenia or schizoaffective disorder), who had undergone MRI scanning and 
clinical and neurocognitive assessments were included in the study (Appendix 2).  
All patients were recruited from psychiatric outpatient clinics in the north-western 
part of Stockholm County in collaboration with Karolinska Institutet. 
Control individuals had previously served as healthy comparison subjects in biological 
psychiatric research at Karolinska Institutet, or were recruited among hospital staff or 
their relatives, or were drawn from a representative sample of the population in 
Stockholm County.  
Exclusion criteria for all subjects were a history of head trauma with loss of 
consciousness >5 minutes, current treatment for substance abuse, and/or somatic 
disorders affecting brain function.  
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Both patients and controls underwent a one and a half-hour neurocognitive 
assessment. The testing took place at different locations within Karolinska Institutet 
and was administered by psychologists in training, supervised by an experienced 
neuropsychologist.  
Clinical assessments 
All patients were assessed for DSM based lifetime diagnosis of schizophrenia using 
reviews of psychiatric records and unstructured interviews and/or with structured 
interviews (Spitzer and Williams, 1988) and parish register data. The interviews were 
performed by psychiatrists trained in Sweden. In this population, record reviews by 
using OCPRIT (McGuffin and Farmer, 1991) have been shown to be a reliable source 
for making DSM-III-R (American Psychiatric Association, 1987) and DSM-IV (American 
Psychiatric Association, 1994) psychosis diagnosis. The ratings were performed by 
psychiatrists trained in the use of OCPRIT by the British developers of the instrument. 
Diagnostic reliability was ascertained by calculating the unadjusted agreement and 
Cohen’s un-weighted nominal kappa among the research psychiatrists performing the 
clinical interviews. Addition of data emerging from structured interviews seldom 
altered a diagnosis based on record analysis alone (Ekholm et al., 2005;Vares et al., 
2006). In contrast, using a structured interview as the only source for giving the 
diagnosis led to poor agreement with diagnosis based on multiple sources (Vares et al., 
2006).  
Controls were assessed for lifetime psychiatric diagnosis (DSM-III-R) using structured 
interviews (Spitzer and Williams, 1988). None of the control subjects were diagnosed 
with schizophrenia. All interviews and diagnostic formulations were performed by a 
psychiatrist trained in Sweden.  
Age of onset of symptoms was defined as onset of psychotic symptoms according to 
reviews of hospital records and interviews. Abuse/dependence of alcohol, solvents or 
drugs according to DSM-III-R criteria was evaluated using all available sources. Data 
obtained on current medication were converted into equivalent doses of Haloperidol 
(Kane et al., 2003). Handedness was ascertained by means of asking the patients which 
hand they preferred when writing, using scissors and throwing/catching a ball. 
3.1.2 TOP 
The TOP study is an ongoing project starting in 2002 with longitudinal clinical, 
neurocognitive, genetic and structural and functional MRI assessments of adult 
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patients with mainly schizophrenia or bipolar spectrum disorders, and healthy 
controls.  
For study II, III and IV, subjects were included between 2003 and 2009. All healthy 
controls and patients with schizophrenia spectrum disorder (schizophrenia, 
schizoaffective disorder or schizophreniform disorder) or bipolar spectrum disorder 
(BD I or II) who had undergone MRI scanning (study II), and full neurocognitive 
assessment (studies III and IV) were included in the thesis (Appendix 2).  
All patients were consecutively recruited from psychiatric in and outpatient clinics 
from four major hospitals in Oslo as part of the TOP study in collaboration with the 
University of Oslo.  
The control subjects were randomly selected from statistical records from the same 
catchment area as the patient groups, and contacted by letter inviting them to 
participate. The healthy control subjects that responded to the letter inviting them to 
participate, received a phone call with questions concerning exclusion criteria, 
followed by a screening for psychiatric symptoms with PRIME-MD (Spitzer et al., 
1994). Controls were asked and excluded from the study if they or any of their first-
degree relatives, had a lifetime history of severe psychiatric disorder (schizophrenia 
spectrum disorders, bipolar disorder or major depression). 
Exclusion criteria for all participants were: a history of moderate or severe head 
injury, neurological disorder, IQ < 65 points, and age outside the range of 18-65 years. 
In study III and IV, neurocognitive performance was included in the analyses, which 
required narrower inclusion criteria; all participants had to have IQ points > 70, and 
Norwegian as their first language, or had received their compulsory schooling in 
Norway, and had to score 15 or above in the forced recognition trial in the California 
Verbal Learning Test (CVLT)-II (Delis et al., 2004). Detailed criteria for inclusion and 
exclusion are presented in each paper. 
All participants underwent a three-hour neuropsychological test battery in a 
standardized order. Clinical psychologists with training in standard 
neuropsychological testing administered the tests, under the supervision of an 
experienced clinical psychologist, specialized in neuropsychology. Reports from the 
clinical and neurocognitive assessments of the participating patients were sent to the 
treatment units after completion. 
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Clinical assessments 
Different trained physicians and clinical psychologists performed clinical assessments 
under supervision of experienced psychiatrists specialized in diagnostic assessment. 
Lifetime diagnoses were based on Structured Clinical Interview for DSM-IV Axis I 
disorders (SCID I module A-E) (First, 2002), and examination of medical records. Close 
family members were contacted with the patient’s approval, for additional information 
when needed. All investigators completed a training course in SCID I assessment, and 
frequent diagnostic consensus meetings were held to assure the best possible 
diagnostic inter-rater reliability. Diagnostic reliability was found satisfactory with 
overall agreement for DSM-IV diagnostic categories of 82% with κ = 0.77 (95% CI: 
0.60-0.94) (Birkenaes et al., 2007). Current positive and negative symptoms were 
rated using the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987). 
Psychosocial functioning in patients was assessed with the Global Assessment of 
Functioning (GAF) scale, split version. Interrater reliability for PANSS positive and 
negative subscales (intraclass coefficients = 0.73) and the GAF scales (intraclass 
coefficient = 0.86) has been found to be satisfactory (Engh et al., 2010). Current 
depressive symptoms were rated using the Inventory of Depressive Symptomatology – 
Clinician rating (IDS-C) (Rush et al., 1996). Current manic symptoms were rated using 
the Young Mania Rating Scale (YMRS) (Young et al., 1978).  
Age was defined as age at MRI scanning. Years of education were registered as years of 
schooling as reported by the subjects during interview. Age at onset (age at first 
contact with mental health care due to a primary symptom, i.e., psychotic symptoms 
for schizophrenia group; or psychotic or affective symptoms for the bipolar group) and 
current use of medication were derived from interviews and medical records. Dose of 
medication was converted to defined daily dose (DDD) according to the WHO 
guidelines (http://www.whocc.no/atcddd). Handedness was determined by hand 
preference when writing. 
In order to obtain a clinically representative sample, all patients were included 
regardless of alcohol and illicit drug use, but abuse/dependency was diagnosed (SCID 
module E) if present.  
3.2 Neurocognitive assessments 
The tests in the neuropsychological test batteries used in the HUBIN and the TOP 
studies were selected for their extensive use in clinical settings, and for commercial 
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availability in the Swedish and Norwegian languages, respectively. Both 
neurocognitive test batteries were semi-computerized. One subtest within each test 
was selected in order to minimize the number of statistical tests. In order to make the 
results from the HUBIN and the TOP studies comparable in this thesis, subtests from 
the test batteries were assigned to the following six specific neurocognitive domains 
(although each test probably requires several and overlapping cognitive skills): Verbal 
learning, working memory, executive functioning/flexibility, verbal IQ, processing 
speed and motor speed. 
 
HUBIN 
The administration of subtests and registration of data was guided by a computer 
program, which is useful for clinical use as well as in research settings. A total of 7 tests 
were administered to the participants. Five domains were used in study I: 
Verbal learning: From the Rey Auditory Verbal Learning Test (RAVLT) (Lezak, 1995), 
the participant was presented a list of 15 words at a rate of one word per second, after 
which the subjects were required to reproduce as many words as they could recall. 
The same list was then repeated four more times with the subjects required to 
reproduce as many words as they could recall. The total number of words repeated 
immediately after 5 reading trials (total A 1-5) was used as a measure of verbal 
learning.  
Working memory: During the Letter-Number-Sequencing test (LNS) (Wechsler, 
1997), the subject was required to sort letters and numbers from a row of alternating 
letters and numbers that were presented verbally, and to separately recall the letters 
and numbers in successive order. The test ranges from two to seven items, with three 
trials at each level. The total number of series recalled was included as a measure of 
working memory.  
Executive functioning: From a computerized version of the Wisconsin Card Sorting 
test (WCST) (Heaton et al., 1993), the subject was asked to sort 64 cards against a set 
of four stimulus cards according to a certain unknown rule: colour, shape or number of 
symbols on the cards. Once the subject had made a specified number of consecutive 
correct matches to the initial sorting principle, the sorting principle was changed 
without warning. The WCST proceeds in this manner through a number of shifts in 
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sorting principle among the three possible sorting categories. The subject is given 
immediate feedback from the computer if the choice is correct or incorrect. The 
computer program computes the test scores. The number of total errors was chosen as 
a measure of executive functioning.  
Flexibility: On Trail Making Test B (TMT B) (Lezak, 1995), the participant was 
required to connect as quickly as possible randomly arranged numbers (from 1-13) 
and letters (from A to L) alternately in successive order on a sheet of paper with a pen. 
Time to complete was used as a measure of flexibility. The tests also measure aspects 
of psychomotor speed and executive functioning.  
Verbal IQ: From the Vocabulary subtest in the Wechsler Adult Intelligence Scale 
(WAIS-R) (Wechsler, 1981), the subject was presented 70 words and was required to 
verbally explain the meaning of the presented words. The correct number of responses 
was used as a measure of Verbal IQ. 
Higher scores equal better performance on all measures except for the TMT B and 
WCST tasks. 
 
TOP 
A semi-computerized test battery was administered to all participants. Test scoring 
was initially calibrated across investigators in order to assure a common scoring 
technique. Premorbid IQ was estimated using the National Adult Reading Test – 
Norwegian version (Sundet and Vaskinn, 2008). From a comprehensive test battery, 
seven tests in total were selected for study III and IV:  
Verbal learning: From the California Verbal Learning Test, Second edition (CVLT-II) 
(Delis et al., 2004), a 16-word list was presented to the subject in a similar manner as 
the RAVLT. The total number of words repeated immediately after 5 reading trials 
(Total A 1-5) was used as a measure of verbal learning.  
Working memory: From the Digit Span subtest in WAIS-III (Wechsler, 2003), the 
participant was presented an increasing number of digits. In the first part of the test, 
the subject was asked to repeat in forward order of presentation, and then in the 
second part backward order of presentation. The maximum number of recalled digits 
was recorded, and the total number of forward and backward recalls was used as a 
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measure of working memory. Notably, the score also demonstrates characteristics of 
attention. 
Executive functioning: The interference control and set-shifting tasks are considered 
to measure aspects of executive functioning.  
Interference control: From the third trial in the Color-Word Interference Test, which is 
part of the Delis-Kaplan Executive Function Scale (D-KEFS) (Delis et al., 2005), the time 
taken for the subject to name the colour of the ink on a list of written names of colours 
that are incongruent with the colour of the ink, was used as a measure of interference 
control.  
Set shifting: From the Verbal Fluency test, which is part of the D-KEFS (Delis et al., 
2005), the subject was asked to generate and alternate between words from different 
categories (fruits and furniture). The number of words generated within 60 seconds 
was used as a measure of semantic set-shift ability.  
Verbal IQ was estimated with the Vocabulary subtest from the Wechsler Abbreviated 
Scale of Intelligence (WASI) (Wechsler, 2007a). The subject was presented 80 words 
and was required to verbally explain the meaning of the presented words. The correct 
number of responses was used as a measure of Verbal IQ. 
Processing speed: In the Digit Symbol Test, part of the WAIS – III (Wechsler, 2003), 
certain digits and symbols are matched on top of a sheet of paper. The subject was 
asked to write the symbols matching the digits, which are played further down on the 
same sheet. The number of symbols written within 90 seconds was used as a measure 
of processing speed.  
Motor speed: On the Grooved Pegboard Test (Klove, 1963), the subject must place 25 
notched pegs into a board with 25 matching holes. Time to complete with the 
dominant hand was used as a measure of motor speed.  
For raw scores, higher scores equal better performance on all measures, except for the 
Color-Word Interference Test and the Grooved Pegboard. 
 
  
40 
 
3.3 MRI assessments 
3.3.1 MR image acquisition 
HUBIN 
All subjects were examined in a 1.5 Tesla General Electronics Signa system at the MR 
Research Center, Karolinska Hospital, Stockholm, Sweden. T1-weighted images were 
acquired using a three dimensional spoiled gradient recalled (SPGR) pulse sequence 
with the following parameters: 1.5 mm coronal slices, no gap, 35º flip angle, repetition 
time 24 ms, echo time 6.0 ms, number of excitations 2, field of view 24 cm, and 
acquisition matrix 256 x 192. From visual inspection, all scans were judged to be 
excellent without obvious motion artifacts.  
TOP 
All subjects were examined in a 1.5 Tesla Siemens Magnetom Sonata scanner (Siemens 
Medical Solutions, Erlangen, Germany) equipped with a standard head coil at Oslo 
University Hospital, Ullevål. After a conventional 3-plane localizer, two sagittal T1-
weighted magnetization prepared rapid gradient echo (MPRAGE) volumes were 
acquired with the Siemens tfl3d1_ns pulse sequence (TE = 3.93 ms, TR = 2730 ms, TI = 
1000 ms, flip angle = 7°; FOV = 24 cm, voxel size = 1.33 x 0.94 x 1 mm3, number of 
partitions = 160).  
3.3.2 MR Image processing  
The FreeSurfer (FS) Software (http://surfer.nmr.mgh.harvard.edu) was used for 
processing of the image files from both sites. The HUBIN image files were processed in 
FS version 1.2, while the TOP image files were processed in FS version 3.0.2. The image 
files in DICOM format were transferred to a Linux workstation for morphometric 
analysis. Images were corrected for non-linear warping caused by gradient coil non-
linearities, using tools developed through the Morphometry Biomedical Informatics 
Research Network (mBIRN) (Fennema-Notestine et al., 2007). From the HUBIN 
database one T1 weighted image was used, and from the TOP database two T1-
weighted images were rigid body registered to each other (motion corrected), and 
subsequently averaged together to increase the signal to noise ratio. An overview of 
the methods used in each study is given in Table 1. FS was used to obtain 
measurements of cortical thickness by reconstructing representations of the 
grey/white matter boundary and the cortical surface, and then calculating the distance 
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between those surfaces at numerous points (vertices) across the cortical mantle (Dale 
et al., 1999;Dale and Sereno, 1993). Vertices were arranged in a triangular mesh with 
approximately 1 mm spacing, allowing for measures of cortical thickness at 
approximately 160 000 points in each hemisphere (Fig. 1).  
 
 
 
Failures in FreeSurfer's initial Talairach alignments were identified by visual 
inspection of all images, and were rectified prior to reconstruction of the cortical 
surfaces. Surface maps were smoothed using a full-width-half-maximum Gaussian 
kernel of 25mm (study I) and 30 mm (study II) and averaged across participants using 
a non-rigid high-dimensional spherical averaging method to align cortical folding 
patterns (Fischl et al., 1999) (Fig. 2). The method is fully described elsewhere (Dale et 
al., 1999;Fischl et al., 1999;Fischl et al., 2001).  
The software also enables surface division into functionally relevant parcellated 
regions (study II and III) (regions-of-interest [ROI]) (Fischl et al., 2004), which are 
neuroanatomically labelled (Desikan et al., 2006) (Fig. 2). Average regional cortical 
thickness was calculated as the average distance between the grey/white boundary 
and the pial surface within each ROI (study II and III). Regional surface area was 
calculated as the sum of the areas of each triangle falling within a given ROI; this was 
done in each subject’s native space (study III). Average cortical thickness 
measurements from parcellated regions were used in study II in addition to cortical 
thickness maps, in order to calculate mean differences and effect sizes in comparable 
regions across the subject groups. Average cortical thickness and total surface area 
within parcellated regions were used in study III in order to be able to directly 
Fig. 1. Illustration of the methods used to 
obtain cortical measures. A) Coronal slice of 
MR image. Cortical thickness measurements 
are obtained by calculating the distance 
between the white/grey matter surface 
(yellow line) and the pial surface (red line) on 
numerous points across the cortex. B) A 
triangular mesh on the reconstructed surface. 
Cortical surface area measurements were 
obtained by summing the areas within each 
triangle within a given region of interest 
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compare measurements of thickness and area within the same regions across the 
subject groups.  
 
 
Fig. 2. Illustration of FreeSurfer methods for cortical analyses A) Visualization of structural anatomy, B) 
Intersubject registration, C) Cortical thickness statistical maps of point-by-point measurements and D) 
Parcellations into functionally regional relevant areas (Appendix 3) (By courtesy of A. Dale and B. 
Fischl). 
 
Subcortical volumes (Fig. 3) were obtained from the automated procedure for 
volumetric measures of brain structures implemented in FreeSurfer (Fischl et al., 
2002) as well as intracranial volume (ICV) estimates (Buckner et al., 2004). 
Topological defects in the automatically determined grey/white matter boundary and 
subcortical volume measurements were routinely manually corrected blinded to 
subject group identity. A total of 27 subcortical structure volumes (including the 
hippocampus and amygdala) were automatically segmented and included in the 
analyses in study II, while a selection of 18 structure volumes were included in study 
IV. The selection of structure volumes was in part based on previously shown group 
differences and in part made to limit the number of statistical tests. All parcellated 
regions and subcortical structure volumes are listed in appendix 3.  
 
  
43 
 
  
Fig. 3. Segmentation of subcortical structure volumes using the FreeSurfer software (Appendix 3). Left, 
coronal slice. Right, sagittal slice (image by L.M. Rimol).  
3.4 Statistical analyses 
The analyses were performed in the statistical software SPSS versions 14.0 and 16.0 
(http://www.spss.com) and FreeSurfer software v. 3.0.2. All variables were checked 
for deviations from a normal distribution and logarithmic transformed if necessary, 
before being entered into the analyses. Demographic, clinical and neuropsychological 
test scores were compared across groups using Student’s T-tests and chi-square 
analyses and analyses of variance (ANOVAs) followed by post-hoc tests. The main 
analyses in all articles were based on General Linear Models (GLMs) with the brain 
structure of interest as the dependent variable. Diagnostic group, age and the 
neurocognitive variables of interest were entered as independent variables. Sex and 
intracranial volume were corrected for, when appropriate. In studies (I and II), GLMs 
were estimated at each vertex across the cortical surface, with cortical thickness as the 
dependent variable, allowing for generation of thresholded statistical maps. Following 
the main analyses, subsequent analyses were performed to check for the effects of 
antipsychotic medication and illness duration, and to investigate categorical subtypes 
within each of the two patient groups separately.  
Different approaches were employed to investigate group differences in 
structure/function relationships in Study I and Studies III/IV (Table 1). In Study I, 
brain cortical regions for which we detected a common effect of neurocognitive scores 
on cortical thickness, were selected for diagnostic interaction analyses. In Studies 
III/IV, brain regions for which we detected groupwise (separate) effects were selected 
for statistical comparisons between groups. We were especially interested in 
relationships in the separate patients groups and specifically aimed to identify 
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different relationships between the schizophrenia and bipolar groups. The 
relationships for the combined group in Study I and for the separate group analyses in 
Studies III and IV were identified at an uncorrected p level of 0.01 and chosen for 
further between-group analyses. By choosing this arbitrary p level, there is always a 
risk of running type I errors in hypothesis testing and thus one might present false 
positive findings as true findings. However, comparable previous studies have 
demonstrated low/moderate strengths in structure/function relationships and some 
researchers have, therefore, chosen to set a significance level at p < 0.025 (Antonova et 
al., 2005) in order to avoid type II errors. Our p level was set lower, and the final 
results were appropriately corrected with multiple comparison control. Application of 
conventional Bonferroni correction on all analyses would probably result in rejection 
of true positive results. Corrections for multiple comparisons were therefore done 
with a false discovery rate (FDR) of 0.05 on the cortical thickness maps, the 
Bonferroni-Holm step-down procedure on comparisons of discrete structures in Study 
II and Bonferroni correction in Studies III and IV. However, due to the high number of 
statistical tests performed some caution must be used when interpreting the results. 
The statistical procedures are described in more detail in the separate articles 
included in the thesis.  
Table 1. Overview of brain measurements and statistical methods 
Study Brain structure Measurement Neurocognitive 
tests  
Statistics 
I Cortical thickness  Vertex-by-vertex  
Regions-of-interest 
5 Combined group 
Interactions 
 
II 
 
Cortical thickness 
 
Vertex-by-vertex 
Parcellated regions 
  
Pairwise comparisons 
 Subcortical 
volumes  
Structure volumes   Omnibus test –  
pairwise comparisons 
 
III 
 
Cortical thickness 
and surface area  
 
Parcellated regions  
 
6 
 
Combined group 
Separate analyses – 
pairwise comparisons  
 
 
IV 
 
Subcortical 
volumes  
 
Structure volumes  
 
7 
 
Combined group  
Separate analyses –  
pairwise comparisons  
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3.5 Ethical considerations 
The HUBIN project is conducted in accordance with the Declaration of Helsinki and 
approved by the local and regional committees for Research Ethics. All subjects have 
given their written consent to participate after a complete description of the study. The 
TOP study has been approved by the Regional Committee for Medical Research Ethics 
and the Norwegian Data Inspectorate. All subjects have given their written consent to 
participate, after a complete description of the study. 
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4. Summary of studies 
Study I 
“Investigating relationships between cortical thickness and cognitive 
performance in patients with schizophrenia and healthy adults”.  
Relationships between frontal and temporal cortical brain volumes and neurocognitive 
performance in schizophrenia have been reported in previous studies. However, the 
results have been inconsistent, which might be due to the methods used. The aim of 
this study was to perform an unbiased exploration of the relationships between 
cortical thickness and several neurocognitive domains across the whole cortical 
mantle, and for the first time, extend the cortical thickness method to schizophrenia 
patients, in order to identify possible localized and specific structure/function 
relationships in schizophrenia.  
From the larger HUBIN cohort, 67 patients with chronic schizophrenia and 69 healthy 
controls underwent MR scanning and neurocognitive assessments at baseline. Cortical 
thickness measurements were obtained at over 160 000 points in each hemisphere for 
each subject.  
In the combined sample of patients and controls, positive relationships were found 
between cortical thickness in frontal and temporal regions and verbal learning and 
executive functioning, and between cortical thickness in frontal, temporal and occipital 
regions and verbal IQ. There were diagnostic interactions for the relationships 
between verbal IQ and the left middle occipital region and the right temporo-occipital 
region. 
In conclusion, we detected localized relationships between cortical thickness and 
specific neurocognitive test scores. Furthermore, the pattern of relationships appears 
similar in schizophrenia patients and healthy controls. There were, however, two 
cortical brain regions in which the relationships were disrupted in the patients with 
schizophrenia as compared to the healthy control subjects.  
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Study II  
“Cortical thickness and subcortical volumes in schizophrenia and bipolar 
disorder” 
Regional cortical and subcortical brain structural abnormalities have consistently been 
demonstrated in schizophrenia. In bipolar disorder, which has been less studied, the 
most frequently shown abnormalities are enlargements of the cerebral ventricles and 
increased frequency of white matter hyperintensities. Although the symptomatology is 
overlapping and genetic studies have detected shared genetic liability between 
schizophrenia and bipolar disorder, few studies have directly compared schizophrenia 
patients with bipolar disorder patients using the exact same methodology in order to 
determine the similarities and differences in brain structural abnormalities.  
From the TOP cohort, MR scans were obtained from 173 patients with schizophrenia, 
139 patients with bipolar disorder (BD) and 207 healthy control subjects. Cortical 
thickness measurements and subcortical structure volumes were obtained for each 
subject.  
The results presented as statistical cortical thickness maps, demonstrated frontal, 
temporal, parietal and occipital cortical thinning in schizophrenia compared with 
healthy controls, while there were no findings for the bipolar disorder group 
compared with the healthy control group, or between the schizophrenia and bipolar 
disorder group. The BD I subgroup displayed cortical thinning in frontal and temporal 
and parietal regions relative to healthy controls, which were partially overlapping with 
the abnormal regions found in schizophrenia, however the cortical thinning in the 
schizophrenia group was more extensive. In the subcortical brain, the schizophrenia 
and bipolar disorder group showed similar abnormalities compared to healthy 
controls; enlarged ventricles, reduced bilateral hippocampi, left thalamus, right 
nucleus accumbens and left cerebellar cortex volumes, and reduced volumes of the 
brainstem. Left amygdala volumes were reduced in schizophrenia relative to healthy 
controls, and right putamen volumes were enlarged in schizophrenia relative to 
bipolar disorder and healthy controls. In general, the effect sizes were larger for the 
schizophrenia group than for the bipolar disorder group, relative to the healthy control 
group. All results remained significant after corrections for duration of illness and use 
of antipsychotic medication.  
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In conclusion, there were similar brain structural abnormalities in schizophrenia and 
BD I in the cerebral cortex and between schizophrenia and the combined bipolar 
disorder group for subcortical structures. These findings are consistent with common 
underlying pathophysiology in schizophrenia and bipolar disorder. However, the 
schizophrenia group displayed more extensive brain structure abnormalities, both in 
pattern and magnitude.  
Study III 
“Brain cortical thickness and surface area correlates of neurocognitive 
performance between patients with schizophrenia, bipolar disorder and healthy 
control subjects”  
Previous studies have demonstrated similar cortical brain abnormalities as well as 
neurocognitive dysfunction between schizophrenia and bipolar disorder. Studies that 
have investigated relationships between cortical characteristics and neurocognition in 
schizophrenia are inconsistent, and very few studies have been performed in bipolar 
disorder. In this study, we included both regional cortical thickness and surface area 
measurements, which together constitute cortical volume, and investigated for 
relationships with several neurocognitive domains across schizophrenia and bipolar 
disorder and healthy controls. We also aimed to clarify differences and similarities in 
cortical brain structure/function relationships between schizophrenia and bipolar 
disorder.  
From the TOP cohort, 519 subjects had undergone MR scanning. From these, there 
were complete neurocognitive data available from 430 subjects, of which 117 were 
schizophrenia patients, 121 were bipolar disorder patients and 192 were healthy 
controls. Average cortical thickness and total surface area measurements were 
obtained from 14 selected parcellated cortical regions in each hemisphere for each 
subject and investigated for relationships with six neurocognitive tests. 
For all subjects combined, one negative relationship was found between cortical 
thickness in the right anterior cingulate and working memory, and several positive 
relationships were found between cortical surface area in frontal and temporal regions 
and various neurocognitive tests. Three relationships were different between 
schizophrenia and bipolar disorder, of which the relationship between cortical 
thickness in the right temporal pole and working memory was specific to bipolar 
disorder, and the relationship between cortical thickness in the left transverse 
  
49 
 
temporal region and processing speed was specific to schizophrenia. Cortical thickness 
in several temporal regions related differently to processing speed in schizophrenia 
relative to healthy controls. The relationship between surface area in the left fusiform 
region and verbal learning in healthy controls was different from that in schizophrenia. 
In general, there were more relationship differences between schizophrenia and 
healthy controls, than between bipolar disorder and healthy controls.  
In conclusion, we have demonstrated that relationships between cortical thickness and 
surface area, and neurocognition show both similarities and differences across 
schizophrenia and bipolar disorder and healthy control subjects. Some disease-specific 
relationships were found and suggest that the clinical significance of cortical brain 
abnormalities may in part be different in schizophrenia and bipolar disorder.  
Study IV 
“Subcortical brain volumes relate to neurocognition in schizophrenia and 
bipolar disorder and healthy controls” 
Subcortical brain structures are anatomically connected with widespread cortical 
regions forming numerous networks, and are hypothesized to modulate motor and 
cognitive behaviour. Structural abnormalities in the subcortical brain have been 
demonstrated in schizophrenia, while bipolar disorder is less studied, and the findings 
are inconsistent. In a previous study (II) we demonstrated almost completely 
overlapping subcortical abnormalities across schizophrenia and bipolar disorder 
compared to healthy controls. The aim of this study was to complement the previous 
study (III) on cortical structures, and investigate the relationships between subcortical 
structure volumes and a range of neurocognitive tests, and to identify similarities and 
differences between schizophrenia and bipolar disorder.  
MR scans and neurocognitive assessments were obtained for 117 schizophrenia 
patients, 121 bipolar disorder patients and 192 healthy controls. The subcortical 
structure volumes were automatically segmented and 9 volumes of interest from each 
hemisphere were chosen for the analyses and investigated for a relationship with 
seven neurocognitive tests. 
For all subjects combined, larger volumes of the ventricles, hippocampus and putamen 
were related to poorer neurocognitive function. The relationships between ventricular 
volumes and motor speed and between putamen volumes and executive functions 
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were similar in schizophrenia and bipolar disorder, but different from healthy 
controls. The relationship between larger left putamen volume and poorer working 
memory was specific to schizophrenia. 
In conclusion, on the background of overlapping subcortical abnormalities and 
neurocognitive dysfunction in schizophrenia and bipolar disorder, we have 
demonstrated both differences and similarities in subcortical structure/function 
relationships between schizophrenia and bipolar disorder. The findings suggest that 
putamen and ventricular volumes may reflect severity of neurocognitive functioning in 
both schizophrenia and bipolar disorder. Altered relationships may also be related to 
disruptions in the cortico-striatal-thalamico-cortical networks subserving or 
modulating neurocognitive functioning.  
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5. Discussion 
First, the main findings are summarized, followed by interpretations of the findings 
(5.1). Then, methodological issues are discussed (5.2).  
5.1 Findings and interpretations 
To summarize, the main findings in the present thesis were:  
 Brain cortical thinning in frontal, temporal and parietal regions is found in 
schizophrenia and bipolar disorder type 1, relative to healthy control subjects. 
The cortical thinning in schizophrenia was more extensive in pattern and 
magnitude compared with bipolar disorder.  
 Subcortical volume abnormalities were found in both schizophrenia and bipolar 
spectrum disorders when compared to healthy controls, but with larger effect 
sizes in schizophrenia. 
 In chronic schizophrenia patients and healthy controls, cortical thickness 
relationships with specific neurocognitive functional domains were positive 
and localized in frontal, temporal and occipital regions. The relationships were 
mainly similar in patients and controls. 
 There were few cortical thickness relationships with neurocognitive 
performance in a replication study, which included both schizophrenia and 
bipolar disorder patients.  
 Larger cortical surface area in frontal and temporal brain regions related to 
better neurocognitive performance across groups regardless of having a 
diagnosis of schizophrenia or bipolar disorder. However, one relationship in the 
left fusiform region appeared to be disrupted in schizophrenia, but not in 
bipolar disorder, compared to healthy controls.  
 Larger volumes of the ventricular system, hippocampus and putamen were 
related to poorer neurocognition across schizophrenia, bipolar disorder and 
healthy controls. 
 Group comparisons of specific structure/function relationships between 
schizophrenia and bipolar disorder demonstrated certain shared and specific 
relationships for both disorders. 
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5.1.1 Brain structure in schizophrenia and bipolar disorder 
Cortical thinning 
The present findings of cortical thinning in schizophrenia are consistent with regional 
thinning reported in studies of chronic (Kuperberg et al., 2003;Nesvag et al., 
2008;Schultz et al., 2010a), first-episode (Crespo-Facorro et al., 2010;Narr et al., 
2005;Schultz et al., 2010b) and in antipsychotic-naïve (Venkatasubramanian et al., 
2008) schizophrenia patients. One study of subjects with high risk for psychosis found 
regional cortical thinning, but to a lesser extent than in schizophrenia subjects 
compared with healthy controls (Jung et al., 2009). Negative findings have been 
reported in first-episode patient studies with small sample sizes (Gutierrez-Galve et al., 
2010;Wiegand et al., 2004) and in relatives of schizophrenia subjects (Goldman et al., 
2009). Some of the previous studies report thinning to be limited to frontal and 
temporal regions (Nesvag et al., 2008), while several other studies also demonstrate 
parietal and occipital (Kuperberg et al., 2003;Schultz et al., 2010a) affection, 
supporting our findings. The present sample was comparably large to those used in 
previous studies enabling detection of subtle changes; the largest effect sizes in the 
current Study II were 3-4 % difference in thickness (equals app. 0.5 Cohen’s d) in the 
lateral and medial frontal regions, and temporo-occipital regions. In comparison, 
reduction in cortical thinning has been reported to be 8-9 % at most in chronic 
patients (Nesvag et al., 2008) and about 4-7 % in FES patients (Schultz et al., 2010a), 
which suggests increasing thinning at later stages of the disease. The timing for 
progression is uncertain, although progression of grey matter loss in transition to 
psychosis (Pantelis et al., 2005) and at the initial stages of the disease has been 
proposed (Jung et al., 2009;Kasai et al., 2003a). Conflicting with the assumed 
progressive grey matter loss, we did not find an effect of illness duration on thinning in 
the present sample and, thus far, no longitudinal cortical thickness study on 
schizophrenia patients has been performed to confirm progressive thinning. 
Preliminary data from our Swedish chronic schizophrenia (HUBIN) cohort do not 
show any progression in cortical thinning or changes of subcortical structure volumes 
over a 5-year period, except from a slight increase of cerebral ventricular size as 
compared with healthy controls. The fact that abnormalities are present in subjects at 
high risk or in early parts of the illness and in AP naïve patients suggest that cortical 
thinning is related to the disorder itself and not mere effects of confounding factors, 
such as medication.  
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Similar patterns of thinning found in frontal and temporal regions in BD I (2-3 % 
difference relative to healthy controls) indicate that cortical thinning is a common 
feature of severe mental disease, at least in schizophrenia and bipolar disorder. We did 
not replicate the suggested cortical thinning scattered across several brain lobes in 
bipolar disorder patients as demonstrated by Lyoo et al. (2006). However, Lyoo et al. 
used a more lenient significance threshold (p < 0.001 uncorrected) and, furthermore, 
thickness of the left middle frontal cortex correlated negatively with duration of 
illness, which is consistent with progressive regional thinning in bipolar disorder, and 
the group of patients in the study by Lyoo et al. was characterized by longer duration 
of illness than the patients in the present study. In contrast, while they did not detect a 
difference between bipolar disorder type 1 and 2, the present Study II demonstrated 
significant frontal, temporal and parietal thinning in BD I, but not in BD II, compared 
with healthy controls. Substantiating the present findings, a just recently published 
cortical thickness study reported cortical thinning in frontal regions in BD I patients 
compared with healthy controls (Foland-Ross et al., 2011). The present BD I and II 
groups were similar on all demographic and clinical variables, except that the BD II 
patients as a group were more depressed (higher IDS score) and were higher 
functioning (higher GAF-F) than the BD I patients. Obviously, all BD I patients had 
experienced manic episodes, and 80 % had a history of psychosis. In the BD II group, 
20 % had experienced a psychotic episode.  
To date, only one study has directly compared cortical thickness between 
schizophrenia and bipolar disorder (Qiu et al., 2008), but the analyses were limited to 
the planum temporale region. Qiu et al. reported similar abnormalities in 
schizophrenia and bipolar disorder consistent with the findings of overlapping 
thinning in the temporo-parietal region in the present study. Although cortical 
thickness is not directly comparable to volume measures, the summarized findings 
from meta-analyses might be of interest for the interpretation of our results. Ellison-
Wright et al. (2010) specifically aimed to review the VBM literature on schizophrenia 
and bipolar disorder, and reported grey matter reduction in bilateral insula and parts 
of the anterior cingulate in both disorders. In the present study, thickness of these 
regions was significantly reduced in schizophrenia, but not in bipolar disorder. 
However, the present effect sizes for the BD I group were intermediate between 
schizophrenia and healthy controls, implying that a larger subject sample of BD I 
patients may have detected the subtle changes that may be present. The present 
thinning in the lateral and medial frontal cortices found in BD I was circumscribed, 
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however still extensive, and these results find support from the frontal cortex volume 
reduction found in bipolar disorder patients as reported in a meta-analysis comparing 
volumetric MRI studies on schizophrenia and bipolar disorder by Arnone et al. (2009). 
Consistent with the present results, both meta-analyses conclude that regional frontal 
lobe reductions in schizophrenia and bipolar disorder are diagnostically unspecific 
(Arnone et al., 2009;Ellison-Wright and Bullmore, 2010). 
Subcortical volumes 
The subcortical abnormalities found in schizophrenia and bipolar disorder in the 
present study, were almost completely overlapping between the diseases. In 
schizophrenia, the findings are consistent with reports from previous studies of 
reduced volumes of the hippocampus (Honea et al., 2005), thalamus and amygdala 
(Ellison-Wright et al., 2008) and cerebellar regions (Honea et al., 2005). Putamen 
enlargement in chronic schizophrenia is consistently found, but has been related to 
treatment with mainly typical antipsychotic medication (Brandt and Bonelli, 2008). 
The present results for right putamen remained significant after correcting for 
medication use. The ventricular enlargements were substantial and consistent with 
the previous literature (Shenton et al., 2001). We expanded on previous findings, and 
reported abnormalities in nucleus accumbens and the brainstem, which neuroanatomy 
might be understudied in schizophrenia.  
An important finding from the present studies is the unexpected extent of subcortical 
abnormalities found in bipolar disorder. The only consistently reported abnormalities 
in the previous literature of bipolar disorder have been ventricular enlargements and 
increased frequency of white matter hyperintensities (Kempton et al., 2008;McDonald 
et al., 2004). Similarly, a later study than ours, analyzed data from a large bipolar I 
sample (n = 321) recruited from different sites, and found increased right lateral 
ventricular size compared with healthy controls (Hallahan et al., 2011). In contrast, a 
study comparing between first-episode patients with schizophrenia and bipolar 
disorder, found larger ventricular volumes in schizophrenia patients, but not in bipolar 
disorder, compared with healthy controls (Rosa et al., 2010). However, the bipolar 
disorder group may have been too small to detect subtle abnormalities at illness onset, 
as ventricular enlargements are shown to be greater in multi-episode than in recent 
onset patients with bipolar disorder (Strakowski et al., 2002). The clinical significance 
of ventricular enlargements is not known, but the majority of longitudinal studies 
relate progression of ventricular volumes to poor outcome in schizophrenia (Ho et al., 
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2003;Kempton et al., 2010). Enlarged amygdala volumes have been found in several 
bipolar disorder studies (Bora et al., 2010). However, this finding might be confounded 
by age, in terms of a positive correlation (Usher et al., 2010a) and use of lithium, which 
has been suggested to have psychotrophic effects (Hallahan et al., 2011;Usher et al., 
2010b). The increased globus pallidum volume found in previous studies on bipolar 
disorder (Arnone et al., 2009) was not replicated in the present study; rather we found 
a trend for an increase in the schizophrenia group exclusively. 
The effect sizes that we present are in accordance with those reported in previous 
meta-analyses (Arnone et al., 2009), although we report smaller effect sizes for 
amygdala volume in schizophrenia, and larger effects for hippocampus in both 
disorders relative to healthy controls, and larger ventricular size effects in bipolar 
disorder relative to healthy controls.  
To sum up, a wide range of cortical and subcortical structures were found to be 
abnormal in schizophrenia and BD I patients. Subcortical volumes were also 
significantly different in the BD II patients, when compared to healthy controls. Thus, 
on a group level there are broad similarities between bipolar disorder and 
schizophrenia in terms of brain structural abnormalities. But overall, the abnormalities 
are more pronounced in schizophrenia.  
Hypothetically, the present findings in schizophrenia and bipolar disorder could be 
due to 1) similar processes with different intensity or 2) different processes with 
similar outcome. Brain structure as a phenotype has been shown to be moderately to 
highly heritable, and since disturbances in brain development is suggested to be one of 
the explanations for schizophrenia, genes involved in brain development might 
overlap with causal genes or candidate genes for these disorders (Kaymaz and van Os, 
2009). One example of the first hypothesis could be that there is a substantial 
polygenic component common to the risk of schizophrenia and bipolar disorder 
involving thousands of common alleles of very small effect, implicating partly shared 
genetic liability for the disorders (Purcell et al., 2009), but that other non-shared genes 
or interactions with other genes could account for the differences in brain structure. 
Also consistent with more extensive findings or a greater intensity in schizophrenia 
are the recent studies that find some of the disease specificity to schizophrenia to be 
associated with structural genomic variations, such as copy number variations (CNVs) 
(Grozeva et al., 2010;Sebat et al., 2009;Stefansson et al., 2008). Also, differences in 
exposure to biological environmental stressors such as viruses and obstetrical 
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complications could affect the common genes differently, leading to differences in 
degree of structural abnormalities.  
The second hypothesis suggests differences in genetic factors and in the underlying 
pathophysiology. One neuropathological study showed cortical density changes 
(similar outcome) in both disorders, but the abnormalities were located in different 
cortical layers (Bouras et al., 2001). MRI cannot detect these microscopic findings with 
the currently employed magnetic fields, which limit the resolution. What appears to be 
common cortical thinning on MRI could reflect differences in cortical cellular 
pathology. Notably, neuropathological studies report conflicting results (Fornito et al., 
2009a), and are confounded by long illness course and medication. In a study by 
Goldman et al. (2009), cortical thickness was shown to be heritable per se, but since 
first-degree relatives of schizophrenia patients did not demonstrate significant cortical 
thinning relative to healthy controls, the authors concluded that the observed thinning 
in schizophrenia was not related to the risk of developing schizophrenia, but rather to 
disease-related factors. Furthermore, a recent investigation of the present study 
sample by Bakken et al. (2011, Submitted), found specific genetic variants on 
chromosome 15 to be associated with the fronto-temporal cortical thinning found in 
schizophrenia, but not in bipolar disorder, nor was it associated with the risk for 
schizophrenia or bipolar disorder. The findings support the hypothesis of different 
aetiology with similar outcomes across schizophrenia and bipolar disorder. 
5.1.2 Neurocognitive performance in schizophrenia and bipolar disorder 
The neurocognitive case-control differences in the HUBIN study, and the TOP study 
respectively, have been addressed elsewhere (Ekerholm and Svala, 2008;Lawyer et al., 
2006;Simonsen et al., 2011). However, a few aspects are relevant to discuss in the 
present thesis. In accordance with previous studies (Heinrichs and Zakzanis, 
1998;Mesholam-Gately et al., 2009;Rund et al., 2006) we found neurocognitive 
dysfunction across all domains in schizophrenia, compared to healthy controls in both 
cohorts. The bipolar disorder group displayed significant impairment on selected 
domains, i.e., motor speed, processing speed, and set-shifting and interference control 
(executive functioning), compared with healthy controls. The findings for bipolar 
disorder are in line with those presented in meta-analyses (Bora et al., 2009). 
However, both the schizophrenia group and the bipolar disorder group in the TOP 
cohort were less severely impaired on verbal learning than expected from the meta-
analyses.  
  
57 
 
Table 2. Overview of effect sizes for neurocognitive group comparisons. 
 
Study  I  III and IV 
Subject group  HC-SCH  HC-SCH HC-BD 
Effect size  d  d d 
Verbal learning  1.25  0.71 0.13 
Processing speed 
   1.10 0.62 
Working memory  0.85  0.54 0.23 
Verbal IQ  0.67  0.42 0.15 
Executive Functioning WCST 0.93 SSH 1.10 0.47 
 TMT B 1.18 INT 0.80 0.53 
Motor speed    0.87 0.79 
HC, healthy controls; SCH, schizophrenia patients; BD, bipolar disorder patients; d, Cohen´s d; WCST, 
Wisconsin Card Sorting Test; TMT B, Trail Making Test B; SSH, Set-shifting; INT, Interference Control.  
 
Overall, the effect sizes in Table 2 were larger in the HUBIN study and comparable to 
those in chronic schizophrenia studies (Heinrichs and Zakzanis, 1998), relative to the 
TOP findings, which were comparable to those found in first episode studies 
(Mesholam-Gately et al., 2009), underlining the differences in the two samples 
employed in our investigations. The differences may in part reflect cohort differences, 
i.e., that the HUBIN patients represented a more severely ill patient group. 
5.1.3 Regional relationships between brain structure and neurocognition  
Cortical thickness 
To our knowledge, study I was the first study to explore relationships between cortical 
thickness throughout the cortical mantle, and neurocognition in schizophrenia. 
Previous studies on structure/function relationships have largely been performed 
using global or regional brain volume measurements, and reported relationships 
between frontal lobe regions and executive functioning (Bonilha et al., 2008;Rusch et 
al., 2007;Seidman et al., 1994;Szeszko et al., 2000) and memory functions (Baare et al., 
1999;Premkumar et al., 2008;Seidman et al., 1994) in schizophrenia. Although more 
inconsistent, there are reports of relationships between the temporal lobe volumes 
and verbal memory (Gur et al., 2000;Nestor et al., 1993;Vita et al., 1995) and executive 
functioning (Nestor et al., 2007) in schizophrenia. Studies on healthy adults have found 
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widespread relationships between IQ scores and cortical volumes (Haier et al., 2004) 
and cortical thickness (Narr et al., 2007). In accordance with the previous literature, 
we found cortical thickness relationships with executive functioning, verbal memory 
and verbal IQ in the frontal and temporal lobe, and relationships with verbal IQ in the 
occipital lobe. In agreement with our expectations, the relationships were not strictly 
confined to pre-selected regions, but included relatively small clusters within regions, 
and in some instances, even surpassed adjacent regions that would normally be 
regarded as separate and thus be investigated separately, with the risk of not being 
detected. In all regions thicker cortex was associated with better performance on the 
cognitive tasks. Therefore, we postulated that these findings could represent nodes 
within cognitive networks, in which structural integrity is important for cognitive 
functioning. However, the relationships were for the most part similar in patients and 
controls, except in discrete temporo-occipital and occipital regions where a diagnostic 
interaction was found for the relationship with verbal IQ. Consequently, the observed 
fronto-temporal cortical thinning in patients with schizophrenia was neither related to 
nor predictive of the cognitive deficits observed in the patient group. Although 
neurodevelopmental damage to the cortical thickness in rats has been found to cause 
selective cognitive deficits (Flagstad et al., 2005), these findings were not replicated in 
the present study on adult chronic schizophrenia patients as measured in vivo with 
MRI. Subsequent to the publication of study I, several studies on cortical 
thickness/neurocognition in schizophrenia patients have been published; one study 
reported an inverse relationship between average cortical thickness in the global and 
parietal lobe with attention in FES patients (Crespo-Facorro et al., 2010), while two 
other FES studies failed to demonstrate any regional relationships (Gutierrez-Galve et 
al., 2010;Roiz-Santianez et al., 2010).  
In study III, the research questions from study I were re-examined in a larger and 
younger study sample. In addition, bipolar disorder patients were included as a second 
clinical group, in order to address the issue of disease specificity. We found only one 
significant cortical thickness relationship in the combined group of subjects, and that 
was different from the ones in study I. The negative relationship between cortical 
thickness in the right rostral anterior cingulate (AC) and working memory in all 
patients and controls combined may partly be accounted for by the inclusion of the 
bipolar disorder group, who displayed the strongest relationship between AC cortical 
thickness and working memory performance. Functional MRI studies have frequently 
shown that working memory functions recruit the AC region (Hartley and Speer, 
  
59 
 
2000), and activity in the AC has been related to adjustment in performance (cognitive 
control), indirectly serving as a signal that engages in regulatory processes in the 
lateral prefrontal cortex, typically thought to be responsible for working memory 
(Ridderinkhof et al., 2004).  
The failure to replicate the results in study I may be due to smaller effect sizes. The 
effect sizes for group differences in cortical thickness and neurocognitive performance 
were smaller in Study III than in those with chronic patients (Heinrichs and Zakzanis, 
1998;Nesvag et al., 2008), which might have limited our ability to detect subtle 
relationships. Alternatively, taken together with the limited findings reported in 
cortical thickness studies of FES patients (Crespo-Facorro et al., 2010;Gutierrez-Galve 
et al., 2010;Roiz-Santianez et al., 2010), the limited findings for cortical thickness in 
Study III may reflect the effects of age (as discussed in section 5.1.4). 
Cortical surface area 
Cortical surface area reduction in certain frontal and temporal regions were found in 
schizophrenia relative to healthy subjects, and is consistent with the regional frontal 
area reductions found in adolescent-onset schizophrenia patients (Voets et al., 2008) 
and temporal area reductions in first-episode schizophrenia patients (Gutierrez-Galve 
et al., 2010). Equal or increased frontal and temporal surface area in bipolar disorder 
compared with schizophrenia patients and healthy controls, accord well with the 
preserved total brain size reported in bipolar disorder (Hoge et al., 1999). Gutierrez–
Galve et al. (2010) reported weak, but significant relationships between regional 
frontal and temporal surface area and current IQ, and between regional frontal surface 
area and working memory in schizophrenia patients, but not healthy controls. By 
increasing the sample size, we were able to demonstrate that relationships between 
frontal and temporal surface area and verbal IQ and working memory are similar 
across schizophrenia, bipolar disorder and healthy controls. Interestingly, we found 
both cortical thickness and surface area in the anterior cingulate region to be related 
to working memory. Previous investigations have found volume of the anterior 
cingulate to be associated with working memory in bipolar disorder (Zimmerman et 
al., 2006), in schizophrenia patients (Szeszko et al., 2000) and in healthy controls 
(Minatogawa-Chang et al., 2009), however, with various directions of effect, which 
could be due to the separate contributions of cortical thickness and surface area to 
volume measurements.  
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Subcortical structures 
The left inferior lateral ventricular volume was related to motor speed in all groups, 
but to a greater degree in both patient groups relative to healthy controls, implying 
that extent of ventricular enlargement is reflected in motor speed impairment, since 
both schizophrenia and bipolar patients were impaired on motor speed performance, 
compared with healthy controls. To our knowledge, this is the first demonstration of 
this specific relationship. However, ventricular volumes have been related to tests 
requiring motor speed, such as TMT B (Lawyer et al., 2006), and enlargement of the 
ventricular system has been demonstrated in diseases typically associated with motor 
symptoms, such as Parkinson´s disease (Dalaker et al., 2010). Surprisingly, enlarged 
ventricular size related significantly to poorer executive functioning only in bipolar 
disorder, which was unexpected since previous studies have demonstrated this 
relationship in schizophrenia (Lawyer et al., 2006;Toulopoulou et al., 2004), but could 
be of importance, since both ventricular enlargements and executive dysfunction are 
frequently implicated in bipolar disorder (Bora et al., 2009;Kempton et al., 2008).  
Hippocampal volumes were related to working memory in all groups, which is in 
accordance with previous studies on bipolar disorder patients (Ali et al., 2000) and 
healthy controls (Cherbuin et al., 2009), while fMRI studies have shown activation in 
the hippocampus during working memory paradigms (Cabeza et al., 2002) in healthy 
subjects. From the literature one would expect the left hippocampus to be associated 
with verbal memory (Toulopoulou et al., 2004), whereas the right hippocampus has 
been shown to be important for spatial memory functioning (Antonova et al., 2004). 
Hippocampus volume relationships with various memory functions may 
hypothetically reflect participation in different networks connecting the hippocampus 
with various cortical regions and subcortical structures, or a common 
encoding/consolidation strategy across a variety of cognitive tasks. Alternatively, 
different subregions within the hippocampus could be associated with different 
neurocognitive tasks, as suggested by the specific CA3 subregion involvement in 
working memory (Kesner, 2007). Inconsistency across studies could also be due to 
methodological differences. For example, the FS segmentation of the hippocampus 
includes volumes of the whole hippocampal complex including the subiculum, fimbria 
and alveus (white matter) in addition to the CA regions and dentate gyrus (Cherbuin et 
al., 2009). Thus, it might not be comparable to manually traced hippocampi by other 
definitions.  
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The putamen volume relationship with verbal learning in all groups replicate the 
association found by Lawyer et al. (2006) in the HUBIN cohort. The strongest 
association was found in the schizophrenia group, suggesting that the normal negative 
relationship observed in healthy controls is exacerbated in schizophrenia.  
The negative relationships in Study III and IV, i.e., that larger brain structure size was 
related to poorer neurocognitive performance, were unexpected in view of the 
findings from Study I of positive relationships only. One might speculate that the 
negative relationships indicate lack of functional pruning during development causing 
inefficient neurocognitive functioning, or a compensatory increase in size through 
synaptic formation in individuals with relatively poorer neurocognitive performance. 
It has been proposed that inverse relationships between hippocampus and 
neurocognition could reflect problems during neuronal migration, which may lead to 
abnormal proliferation of neurons and neuronal connections and, consequently, an 
increased size of the hippocampus. The resulting increased size may subsequently lead 
to inefficient information processing (Chantome et al., 1999). Alternatively, the inverse 
structure/function relationships in the younger TOP cohort may be due to age effects. 
5.1.4 Effects of age 
Normal ageing is characterized by overall brain tissue atrophy accompanied by 
ventricular enlargement. Cross-sectional studies on healthy subjects have 
demonstrated continuous decline in cortical thickness (Fjell et al., 2009a;Salat et al., 
2004;Tamnes et al., 2010a) and subcortical volumes (Ostby et al., 2009;Raz et al., 
2003;Walhovd et al., 2009) from late childhood into old age with considerable regional 
variability. Cortical thickness in prefrontal regions show the greatest age-related 
decline, while the medial temporal lobe is relatively spared (Lemaitre et al., 2010). The 
findings for surface area indicate a more homogeneous age decline across the cortex, 
and surface area is presumed to be less affected by normal ageing (Lemaitre et al., 
2010).  
Concurrent with the brain structure changes that occur during development, driven by 
pruning (elimination of excess neurons, synapses and dendrites) or myelination along 
the white matter/grey matter border, cognition continues to improve throughout 
childhood (Courchesne et al., 2000;Giedd and Rapoport, 2010;Sowell et al., 
2001;Tamnes et al., 2010b). Cognitive decline begins in early adulthood for most 
neurocognitive measures, such as working and verbal memory and speed of 
processing. Vocabulary, which is an experience dependent measure, is stable until late 
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adulthood (Salthouse, 2010). However, the exact age for peak performance for each 
cognitive task remains poorly defined. Consequently, the normal relationships 
between brain structure measurements and cognitive performance change over time 
and, the results from scientific studies depend on the age range of the subject sample 
under investigation.  
Earlier reports suggested accelerated age-related brain tissue loss in schizophrenia 
compared with healthy subjects (Hulshoff Pol et al., 2002). However, successive 
studies have found similar age effects on cortical thickness reduction in first-episode 
(Wiegand et al., 2004) and chronic (Kuperberg et al., 2003;Nesvag et al., 2008) 
schizophrenia, compared with healthy controls. With regard to structure/function 
relationships, similar effects of age have been found for schizophrenia patients and 
healthy controls (Premkumar et al., 2008), with stronger relationships in older 
subjects than in younger subjects. The different results for cortical structure/function 
relationships in the relatively older and younger cohorts in study I and study III, 
respectively, suggest that age effects are confounds that were not properly adjusted for 
by including age as a covariate.  
Van Petten (2004) suggested three theories for structure/function relationships based 
on observations from studies on hippocampal volumes and memory functions in 
healthy subjects. The theories could also apply to other structure/function 
relationships and relationships in mental diseases. First, the bigger is better hypothesis 
simply suggests that larger brain structure size results in stronger or better function 
regardless of the underlying causative factors. Second, the neuropsychological 
perspective posits that any normal structure will support normal function, and that loss 
of tissue will lead to decline in function. However, taking into account normal ageing, 
with volume loss and cognitive decline, the timing for the onset of “ageing” needs to be 
defined for each brain structure, and for each neurocognitive domain. This theory 
predicts increasingly positive correlations between structure and function during 
ageing. Third, the developmental perspective emphasizes the concurrent grey matter 
tissue loss and cognitive improvement during childhood and adolescence. This theory 
predicts increasingly negative structure/function correlations from the onset of 
developmental tissue loss until the peak of cognitive performance. The two latter 
hypotheses may be combined. 
The present findings of widespread positive cortical thickness relationships in the 
older cohort (Study I) and negative relationships in the younger cohort (Study III) 
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support the theory of increasingly positive relationships when brain tissue decrease 
related to ageing, consistent with the neuropsychological perspective. The main focus of 
the structure/function studies was that of diagnostic effects. Therefore, we did not 
specifically investigate the effects of age in the present studies. Investigations of age 
effects in a sample consisting of two patient groups and a healthy control group are 
highly complex, since different brain structure and cognition trajectories might 
hypothetically exist for all groups in the present sample.  
5.1.5 Disease specific relationships 
The relationships between brain structure and neurocognitive functioning 
demonstrated in the present studies were for the most part similar for all subject 
groups, but some relationships were specific to schizophrenia and/or bipolar disorder. 
These differences in relationships may provide valuable information about underlying 
pathophysiology and biological quantitative traits that may help to reduce the 
phenotypic heterogeneity of psychosis.  
Most of the between-group differences for cortical relationships were near or within 
the temporal lobe. Different relationships between temporo-occipital cortical 
thickness and surface area and verbal abilities were found between schizophrenia 
patients and healthy controls. The temporo-occipital region is important for word 
recognition and is activated during word reading tasks in fMRI studies (Brem et al., 
2006), with a left lateralization activation pattern. The present results suggest that 
these regions have been specifically excluded from the normal functioning network 
underlying word processing in schizophrenia. Also, there were diagnostic group 
interactions between schizophrenia and healthy controls for the relationships between 
cortical thickness and processing speed in several temporal brain regions. Processing 
speed performance, which has been proposed to represent a more generalized 
cognitive feature underlying other speed-dependent cognitive tasks (Dickinson et al., 
2007), has previously been related to widespread brain regions (Sanfilipo et al., 2002). 
However, only the present relationship between transverse temporal cortical thickness 
and processing speed was found to be different from both bipolar disorder and healthy 
controls, and consequently, specific to schizophrenia. Interestingly, Kasai et al. (2003a) 
reported progressive grey matter reduction in the transverse temporal region in the 
early stages of disease specifically in schizophrenia, and not in affective psychoses. 
Moreover, the observed grey matter decline was associated with clinical scores of 
disorganization. In sum, these findings suggest that grey matter integrity in the 
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transverse temporal region may be important for clinical and cognitive functions 
known to be affected in schizophrenia. 
To my knowledge, this is the first study (III) to demonstrate a specific relationship 
between size of temporal lobe cortex and working memory performance in bipolar 
disorder. Functional MRI studies have found abnormal activation in the temporal 
cortex during working memory tasks in bipolar disorder patients relative to healthy 
controls (Adler et al., 2004;Monks et al., 2004) and reduced fronto-temporal 
connectivity in pediatric bipolar disorder (Dickstein et al., 2010). The frontal lobe has 
consistently been implicated in working memory performance and, the present 
temporal pole abnormalities may be secondary to frontal lobe dysfunction.  
We found specific relationships between left putamen volumes and working memory 
in schizophrenia and, common relationships between right putamen volumes and set-
shifting in schizophrenia and bipolar disorder. Putamen, which is part of the dorsal 
striatum, is functionally and anatomically connected with other parts of the brain and 
participates in parallel loops, forming the so-called cortico-striatal-pallido-thalamo-
cortical circuitries. Several of the loops include prefrontal and temporal non-motor 
areas (Alexander et al., 1986;Middleton and Strick, 2000). Although putamen is 
primarily connected with sensori-motor cortical regions, the loops have been shown to 
communicate with each other, enabling influence on other cortical regions known to 
be involved in higher order cognitive functioning. Thus, the differences in relationships 
between putamen and working memory and set-shifting in schizophrenia and bipolar 
disorder patients compared to healthy controls may be due not only to pathology 
directly related to putamen structure volumes, but also to any part of the several 
parallel loops involving the putamen. 
Elevated striatal dopamine levels have consistently been shown in schizophrenia 
patients (Howes and Kapur, 2009) and there is evidence that striatal dopaminergic 
abnormalities are linked with cognitive dysfunction (Simpson et al., 2010) in the 
disease. Of pathophysiological relevance to the present findings, Kellendonk et al. 
(2006) performed a study on transgenic mice, that were overexpressing D2 receptors 
in the striatum, and showed that the mice exhibited selective deficits in working 
memory and flexibility compared with those with normal levels of dopamine, and that 
the deficits remained after the overexpression was switched off, thus suggesting that 
developmental changes caused the cognitive deficits. Furthermore, the striatal 
dopamine levels affected the level of prefrontal dopamine transmission; however, it is 
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not known whether the cognitive dysfunction is primary or secondary to striatal 
dysfunction.  
The relationships between left lateral ventricular volumes and motor speed were also 
similar in schizophrenia and bipolar disorder, and significantly stronger than, but not 
opposite to the relationships found in healthy controls (see section 5.1.3).  
According to the previously presented hypothesis (section 1.8.1), among the 
assumptions for specific relationships in schizophrenia and bipolar disorder were that 
the patient groups evidenced both brain structure reduction and cognitive 
dysfunction. In the present samples, the schizophrenia groups showed significant 
widespread brain structure abnormalities and neurocognitive dysfunction, although 
the effect sizes were greater in the HUBIN study (Study I) than in the TOP study (study 
III and IV), for both measures. The abnormalities in the bipolar group were less 
extensive for both brain structure and neurocognition, and some results were specific 
to the bipolar I disorder subgroup. Consequently, specific relationships in both groups 
were expected, but with a greater number of specific relationships in schizophrenia 
relative to bipolar disorder, which was true for the present studies. Larger inter-
individual variability in brain structure and neurocognitive measures between 
schizophrenia patients compared to bipolar patients, and between bipolar patients 
compared to healthy controls could also account for the differences in number of 
relationships. Larger variability increases the probability to detect statistical 
relationships.  
To summarize, the investigations of structure/function relationships in two 
independent samples demonstrated significant but subtle or weak relationships. This 
is in line with previous investigations in the field. Our comprehensive investigation of 
brain structures yielded relationships with neurocognition in both cortical and 
subcortical regions, consistent with the theories of brain networks as important for 
neurocognitive functioning. Certain specific relationships in schizophrenia and/or 
bipolar disorder were found and could reflect disturbances in specific regions within 
the networks underlying specific cognitive functions. One cannot automatically infer 
biological interaction from statistical interaction, but if our findings are replicated, 
they suggest that having a diagnosis of schizophrenia and bipolar disorder influence 
regional relationships between brain structure and neurocognition to some extent. If 
the demonstrated disrupted relationships are not replicated, and in consequence 
might not be true, the causes of structure abnormalities and cognitive impairment in 
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schizophrenia and bipolar disorder may be independent rather than interdependent, 
and these characteristics represent different, but co-occurring disease-related 
trajectories.  
5.2 Methodological issues 
5.2.1 Medication as confounding factor 
Information on current medication was obtained during clinical interview, from the 
medical record, and by asking the patient’s therapist if necessary. The description of 
types and dosages of medication used by the patient are considered to be quite 
accurate. However, we do not know to what extent the patients, chiefly the outpatients, 
were compliant to their treatment regimens. And even if fully compliant, individual 
differences in metabolism may have affected the biological significance of each 
medication. Both typical and atypical antipsychotics have been found to have an effect 
on cortical grey matter volumes, but findings are inconsistent (Smieskova et al., 2009). 
Studies on high-risk individuals (Fusar-Poli et al., 2010;Jung et al., 2009) and 
neuroleptic-naïve patients (Venkatasubramanian et al., 2008), which avoid the 
potentially confounding medication effects, show cortical abnormalities qualitatively 
similar to those found in medicated schizophrenia patients. Furthermore, some studies 
report that atypical antipsychotics even increase cortical volumes (Scherk and Falkai, 
2006), implicating that findings of cortical brain reduction is, at least in part, related to 
having a psychotic disorder. For the basal ganglia, several reviews have reported that 
typical AP increase striatal volumes, while the atypical medication effects are inverse, 
or even reverse the enlargements exerted by typical AP medication (Brandt and 
Bonelli, 2008;Navari and Dazzan, 2009). We have found no significant effects of 
antipsychotic medication on the cortical or subcortical brain structure measures used 
in the present studies. 
Only 14 % of the patients in the bipolar disorder group and 2 % of the patients in the 
schizophrenia group (study II) used lithium. Thus, due to the small numbers, there 
were limitations to the statistical analyses of a lithium effect on brain structure. 
Previous studies have found lithium use to be associated with increased grey matter 
volume in the anterior cingulate gyrus (Phillips et al., 2008), increased amygdala 
(Usher et al., 2010b) and hippocampus volumes (Hallahan et al., 2011). Differences in 
the proportion of patients using lithium between studies could explain some of the 
heterogeneity in the bipolar disorder literature. The mechanisms for medication effect 
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on brain structure have been proposed to be those of neurotoxicity or neuroprotection 
(Thompson et al., 2009). Neither lithium nor AP use were found to have a significant 
effect on the group differences in neurocognitive performance in a previous study on 
the TOP study sample (Simonsen et al., 2011).  
In conclusion, due to the study design of a naturalistic study, the complete effects of 
medication are not known. And although we have statistically corrected for the 
potential effects of medication, we cannot completely exclude the possibility that the 
present brain structure abnormalities and relationships with neurocognition are 
partially related to medication use. 
5.2.2 Other confounding factors  
Potential demographic and clinical confounders were controlled for, unless considered 
to be illness related. However, in a naturalistic setting, there are variables that were 
not measured or are poorly defined or unknown and were consequently not corrected 
for, but which might affect the results. Brain structure and neurocognitive 
measurements may vary according to differences in sex, symptoms, smoking status, 
substance and alcohol abuse, stress, nutrition state, or other social factors (Weinberger 
and McClure, 2002).  
Sex distributions were different between groups in all four studies and were 
consequently corrected for. Regional cortical thickness differences between men and 
women have been found by some (Luders et al., 2006;Sowell et al., 2007), but not all 
investigations (Fjell et al., 2009b) of healthy adults. We have found no effect of sex 
differences on regional cortical thickness in any of the present subject groups. The 
effect of sex on regional surface area appear to depend on whether the analyses are 
corrected for whole-brain volume or not and, whole-brain volumes and sex are highly 
correlated (Luders and Toga, 2010;Nopoulos et al., 2000). In the present study of 
cortical surface area (III), sex was a significant covariate and was therefore included in 
all analyses. In general, women perform better than men on neurocognitive tasks, but 
sex differences have not been found to affect the observed group differences in the 
TOP sample (Simonsen et al., 2011).  
Symptom severity may relate to brain structure (Nesvag et al., 2009) and 
neurocognition. Negative symptoms in particular have been found to correlate with 
neurocognition (Dominguez et al., 2009;Nieuwenstein et al., 2001). In order for the 
patients to be included in the study in the first place, they had to complete a 
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comprehensive interview, blood tests, and MRI and neurocognitive assessments and 
accordingly had to be in a stable phase of the disease. Thus, symptom load is expected 
to demonstrate small effects on the present analyses.  
The current subject sample included patients with substance and alcohol abuse. We 
performed the analyses without the subjects who had reported current cannabis abuse 
and found the same results. The effect of alcohol consumption has previously been 
investigated in the HUBIN sample, showing effects on white matter tissue volumes, but 
not grey matter tissue volumes (Nesvag et al., 2007). Education and current IQ were 
considered to be illness-related factors in all studies and the observed group 
differences were, therefore, not controlled for. A study representing an overlapping 
sample with the present, found no effect of differences in education and IQ on group 
differences in neurocognitive functioning between schizophrenia and bipolar disorder 
(Simonsen et al., 2011). 
Last, in accordance with the notion that the neurons of the brain exhibit synaptic 
plasticity, as evident through formation and reformation or maintenance of dendrites 
and synapses, a number of MRI studies have investigated brain changes related to 
experience or cognitive and physical training. Grey matter changes have been found as 
a direct consequence of cognitive training in longitudinal studies (Draganski et al., 
2004;Draganski et al., 2006;Engvig et al., 2010). Accordingly, lack of training or 
experience in mentally ill individuals who are unemployed or unable to sustain normal 
social and cognitive activity, could hypothetically account for parts of the smaller grey 
matter measures observed in mental illnesses, at least in those with advanced disease. 
5.2.3 Neurocognitive assessments 
Neuropsychological functioning has been proposed to be well suited for investigations 
of structure/function relationships in schizophrenia and bipolar disorder, since 
dysfunction appear to be trait, rather than state dependent and is relatively stable 
after illness onset. Previously, there has been a lack of consensus on a standard way to 
separate cognitive functioning into key dimensions, or identify the cognitive process 
that is assessed with each cognitive test. The MATRICS (Measurement and Treatment 
Research to improve Cognition in Schizophrenia) initiative, for which one of the 
primary goals was to develop a cognitive battery for treatment evaluation, identified 
major separable cognitive domains in schizophrenia, based on statistical factor 
analyses (Nuechterlein et al., 2008). Of relevance to the present topic, these domains 
were also to serve as a basic structure to understand the underlying nature of 
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cognitive impairment in such disorders. The selected standardized neuropsychological 
tests used in the present thesis are not equal to, but accord well with those found in 
the MATRICS battery, with a few exceptions. We did not include measures of sustained 
attention or visual memory learning and memory. Especially measures of sustained 
attention have been related to grey matter measures in healthy subjects (Salgado-
Pineda et al., 2003;Westlye et al., 2011). However, the selection of tasks was limited in 
order to restrict the number of statistical tests. For the current analyses we used single 
tests from each domain, and in this way we might have missed relationships with other 
relevant cognitive functions. For instance, the selected verbal learning tests only 
included measures of immediate learning from lists, while tests of delayed recall and 
story learning was not included. In the TOP sample immediate verbal learning was 
highly correlated with short delayed list recall and long delayed list recall (r = 0.83), 
while the correlation with story learning, as measured with the Wechsler Memory 
Scale (Wechsler, 2007b) was moderate (r = 0.30). By using single tests from widely 
used neuropsychological tests, instead of data-derived composite scores, direct 
replications of the current findings and comparisons across studies are facilitated.  
The TOP sample is characterized by higher IQ scores than expected from the previous 
literature both in the patient and healthy control populations. The measure of current 
IQ was based on the WASI (Wechsler, 2007a). However, the WASI does not contain 
measures of processing speed or working memory. A previous thesis from the TOP 
study reported IQ to reduce from 106.5 to 100.6 in the schizophrenia group if the Digit 
Symbol and Digit Span tasks were included in accordance with WAIS III (Vaskinn, 
2008). Still, higher than average IQ scores may reflect that high functioning individuals 
with academic interests have been more likely to participate in the TOP study. 
Alternatively, this may suggest that the current outpatients and non-acute inpatients 
are in fact better functioning than indicated by studies with different recruitment 
procedures than in TOP. 
5.2.4 MRI measurements and processing 
For both MR scanner sites, the acquisition parameters were optimized for increased 
grey/white matter image contrast. All MR images were evaluated for gross 
neuropathology by neuroradiologists. MR scanning of patients and controls were 
performed concurrently during the whole study periods thus securing that time did 
not confound the results and, there were no scanner upgrades during the study 
periods. The same magnetic field strength was used at both sites, but there were still 
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minor differences in MR data acquisition between the two sites that might impinge on 
a comparison of the results, such as number of acquisitions, different pulse sequences 
and manufacturers (Han et al., 2006).  
Previous reviews have commented on the variability in how cortical brain regions and 
subcortical structure volumes are defined, leading to difficulties in the interpretation 
of findings across studies (Antonova et al., 2004;Crespo-Facorro et al., 2007a). The 
cortical region boundaries (parcellations) as defined by the FreeSurfer software are 
anatomically valid and parcel the brain regions into functionally relevant 
compartments. Furthermore, using a standardized method facilitates replications in 
independent samples. The methods used for the cortical measures in FreeSurfer have 
been validated by histological (Rosas et al., 2002) as well as manual measurements 
(Kuperberg et al., 2003). For sub-cortical segmentation, reliable measurements have 
been shown for ventricle, hippocampus, caudate, putamen, pallidum and brainstem 
volumes (Fischl et al., 2002;Morey et al., 2009) and across multiple acquisitions 
within-scanners (Jovicich et al., 2009). The reliability of relationships between cortical 
thickness and cognitive performance has been tested across scanners and at different 
time points. The results were shown to be highly reliable in terms of both spatial 
localization and magnitude of absolute cortical thickness measurements (Dickerson et 
al., 2008). Hippocampus volumes that were automatically segmented by FreeSurfer 
and manually traced have been found to show essentially equal relationships with 
working memory performance (Cherbuin et al., 2009). No formal validity or reliability 
testing was performed for the processing of MR images. However, the automated 
procedures need only minimal manual intervention, which was performed without 
knowledge of the subjects’ group identity. The data images from both data sets were 
processed by laboratory assistants. The assistants working on the TOP data were part 
of the FreeSurfer laboratory in San Diego. Laboratory assistants working at the 
Institute of Psychology in Oslo processed the HUBIN data set and, were closely 
supervised by senior researchers who have received their training from the FreeSurfer 
group at Harvard University. 
5.2.5 Diagnostic categories 
All diagnoses were made according to the DSM manual, in which schizophrenia and 
bipolar spectrum disorders are mutually exclusive. Yet difficulties in delineating the 
disorders and their subtypes against each other are common in clinical practice due to 
symptom overlap. In studies like the present, where patients are categorized according 
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to diagnosis, and subsequently compared with each other on a group level, great care 
must be used in the diagnostic assessments. For instance, the schizoaffective disorder 
group differs from the bipolar disorder group only by having psychotic symptoms in a 
certain period of time, without simultaneous affective symptoms. In the HUBIN study, 
diagnostic reliability between researchers performing clinical interviews was 
ascertained by calculating agreement and Cohen’s un-weighted nominal kappa among 
the research psychiatrists performing the clinical interviews. Also, the psychiatrists 
who rated the record reviews using OPCRIT, which has been shown to be a reliable 
source for making DSM psychosis diagnosis (McGuffin and Farmer, 1991), had 
received their training by the British developers of the instrument. The diagnostic 
evaluations in the TOP study were discussed in frequent consensus meetings 
supervised by experienced psychiatrists specialized in diagnostic assessments. In 
order to optimize reliability, all interviewers in the TOP study participated in 
standardized training in all parts of the protocol (also for PANSS and GAF). Tests for 
inter-rater reliability were conducted for the SCID diagnoses with a kappa for 
concordance of diagnosis of 0.77 (Birkenaes et al., 2007). Last, about 1/3 of the 
patients in study II were followed as part of a longitudinal study, and information from 
follow-up visits was used to secure correct diagnoses, ensuring temporal stability.  
5.2.6 Representativity 
The HUBIN and TOP studies have recruited patients from the Swedish and Norwegian 
health care system respectively. Both systems are based on catchment area patient 
admittance systems, which provide public mental health care to all individuals with 
severe mental illness within a given catchment area, resulting in high degree of patient 
representativity. However, patients who for some reason were not treated at 
psychiatric units or were not able or willing to consent to participate in the studies 
were not eligible for examination. The control subjects were randomly selected from 
statistical records and were from the same catchment areas as the patients. Not all 
responded to the invitation to the study. Those who did participate are expected to be 
biased towards higher education, better social adjustment and to be more than 
average interested in research than in the general population.  
5.2.7 Limitations 
The cross-sectional design limits inferences about causality. In case causality has been 
implied by the use of terms like “predictor” in the regression models, I would like to 
emphasize that all relationships in the present thesis are mere correlations of 
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phenotypes. Also, this design limits our understanding of the course of brain structure 
alteration and cognitive decline; for example, the performance of an individual on 
neuropsychological tests might be perceived as within the normal range while the 
subject in question, in fact, had experienced decline from a high-performing level 
during the course of illness. Also, rate of change, not captured in a cross-sectional 
design, may be associated with cortical thickness changes (Murphy et al., 2010). 
The statistical models used in the present studies were based on the assumption of 
linear relationships between structure and function; yet, non-linear relationships 
might better explain some of the relationships. Moreover, only correlational analyses 
were performed in the present studies. A different approach could be to compare brain 
structure measurements between patient groups based on degree of neurocognitive 
impairment (Rusch et al., 2007;Wexler et al., 2009). In general, dividing a sample into 
sub-samples lower the statistical power in the analyses. In order to do a meaningful 
comparison, one would have to compare those without impairment with those who 
are severely or clinically impaired. Clinically significant impairment is often defined as 
scores equal or below 1.5 SD below the mean of the controls. Simonsen et al. (2011) 
found 33% of the schizophrenia group and 23% of the bipolar disorder group in the 
TOP study sample to be impaired by this definition, rendering small groups to be 
compared. In addition, both the brain structure measurements and the neurocognitive 
score distributions, demonstrate great overlap between the groups with unimodal 
distributions. By using a longitudinal design, comparing brain structure between 
patients with significant cognitive decline over time with cognitively stable patients 
would be possible, which in turn could yield clinical meaningful information, 
enhancing our ability to predict outcome.  
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6. Conclusion 
The studies in the present thesis have demonstrated widespread brain structure 
abnormalities that are similar in schizophrenia and bipolar disorder, which is 
consistent with common underlying pathophysiology. However, the findings from the 
current thesis do not show that cognitive dysfunction in schizophrenia and bipolar 
disorder have common brain structural correlates that are deviant from what is found 
in healthy controls. In fact, there were only two such relationships that were common 
to both patient groups. Brain structure abnormalities in schizophrenia are more 
pronounced compared to bipolar disorder and, there were more structure/function 
relationships that were specific to schizophrenia than to bipolar disorder, confirming 
the more extensive abnormalities in schizophrenia. Specific relationships between 
brain structure and neurocognition in schizophrenia and/or bipolar disorder could 
reflect disturbances in specific regions within the brain networks underlying specific 
cognitive functions. 
Future research  
The current findings suggest that age effects should be considered when conducting 
structure/function studies. In order to disentangle the effects of age and illness 
duration, and to investigate structure/function relationships in different stages, 
longitudinal studies of large samples are needed. Also, enhanced cognitive abilities 
concurrent with reductions in brain structures in childhood and adolescence may 
imply that refinement in connectivity, rather than or in addition to grey matter 
amount, is beneficial for cognitive performance. Thus, multimodal studies including 
fMRI and DTI measures to study connectivity and white matter integrity could 
elucidate some of the processes accompanying cognitive changes related to disease.  
Suggestions for future studies 
 Replication. Being the first comprehensive study to compare cortical thickness 
and the relationship with neurocognition across schizophrenia, bipolar 
disorder and healthy controls, our results need to be replicated in independent 
samples  
 The statistical analyses in the present studies were limited to general linear 
models. There are reports of high specificity and sensitivity in diagnostic 
predictions, using advanced statistical models, such as Principal Component 
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Analysis (PCA) on brain structure measurements and neuropsychological test 
scores combined. The results from using other statistical clustering models 
remain largely unexplored. The ability to predict diagnosis can contribute to the 
clinical work and help defining phenotypes in psychiatric research.  
 Longitudinal study. The currently used data are part of a longitudinal study. 
Results from longitudinal studies will aid in the understanding of individual 
brain structure and neurocognitive trajectories and how, and if, they are inter-
related. Optimally, such a study should meet several criteria: (1) a large first 
episode sample; (2) a large healthy control sample; (3) a low attrition rate in 
both samples in order to ensure that they are representative; (4) surveillance 
over an adequate period of time to determine the pattern and degree of change; 
(5) sampling with multiple time points in order to determine the pattern of 
change and its relation to the time of onset.  
 White matter integrity as measured with DTI and subcortical white matter 
volume relationships with neurocognition may complement the present 
findings.  
 Surface area relationships with IQ. Results from previous studies indicate 
differential regional relationships between surface area and general 
neurocognitive measures such as IQ, between schizophrenia patients and 
healthy controls. However, no study has explored such relationships across the 
whole cortical mantle in a large subject sample such as the present. 
Unpublished work from our group demonstrates regional surface area 
abnormalities specifically in schizophrenia, compared with bipolar disorder 
and healthy controls. Further investigations of putative relationships with 
general cognitive functioning might add to the understanding of the functional 
relevance of these findings. 
 Genetic and environmental effects on structure/function relationships. Mainly 
similar structure/function relationships in the patient and healthy populations 
were found in the present thesis. Genetic variation and environmental factors 
such as obstetrical complications, may modulate the relationships, and 
differentiate between patients groups and healthy controls.  
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Appendices 
 
Appendix 1. Diagnostic subtypes 
Schizophrenia spectrum (and other 
psychotic) disorders 
Bipolar spectrum disorders 
  
 Schizophrenia  Bipolar I disorder 
 Schizophreniform disorder  Bipolar II disorder 
 Schizoaffective disorder  Cyclothymic disorder 
 Delusional disorder  Mood disorder due to a general 
medical condition 
 Brief psychotic disorder  Substance-induced mood disorder 
 Shared psychotic disorder  Bipolar disorder not otherwise 
specified (NOS) 
 Psychotic disorder due to a general 
medical condition 
 
 Substance-induced psychotic 
disorder 
 
 Psychotic disorder not otherwise 
specified (NOS) 
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Appendix 3. List of brain structure segmentations from FreeSurfer 
Cortical regions (parcellations) 
 
Subcortical regions 
 
Banks superior temporal sulcus 
Caudal anterior cingulate 
Caudal middle frontal 
Corpus callosum 
Cuneus 
Entorhinal 
Fusiform 
Inferior parietal 
Inferior temporal 
Isthmus cingulate 
Lateral occipital 
Lateral orbitofrontal 
Lingual 
Medial orbitofrontal 
Middle temporal 
Parahippocampal 
Paracentral 
Pars opercularis 
Pars orbitalis 
Pars triangularis 
Pericalcarine 
Postcentral 
Posterior cingulate 
Precentral 
Precuneus 
Rostral anterior cingulate 
Rostral middle frontal 
Superior frontal 
Superior parietal 
Superior temporal 
Supramarginal 
Frontal pole 
Temporal pole 
Transverse temporal 
 
Hippocampus 
Amygdala 
Thalamus 
Lateral ventricle 
Inferior lateral ventricle 
Third ventricle 
Fourth ventricle 
Nucleus accumbens 
Ventral diencephalon 
Cerebellar cortex 
Cerebellar white matter 
Caudate 
Putamen 
Pallidum 
Brainstem 
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Errata 
Study II: 
Page 42, section Subjects, second paragraph and Table 1, line 10: “Positive and 
Negative Symptom Scale” should be “Positive and Negative Syndrome Scale”. 
Page 43, Table 1, line 10 in footnotes, “(http://www.whocc.no/atcdd)” should be 
“(http://www.whocc.no/atcddd)”. 
Page 45, Figure 2 B), the figure with effect sizes of Controls - Bipolar 1 (bottom row) 
has been replaced with Controls – Bipolar. The right figure should be: 
 
Page 45, Figure 2, figure legend should read: ... (B) Upper row: bipolar disorder Type 1 
versus schizophrenia, and bottom row: healthy control subjects versus bipolar 
disorder Type 1 (Schizophrenia = schizophrenia, schizophreniform disorder, and 
schizoaffective disorder). 
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Abstract:  
Relationships between cortical brain structure and neurocognitive functioning have been reported 
in schizophrenia but findings are inconclusive, and only a few studies in bipolar disorder have 
addressed this issue. This is the first study to directly compare relationships between cortical 
thickness and surface area with neurocognitive functioning in patients with schizophrenia (n=171) 
and bipolar disorder (n=121) and healthy controls (n=192). 
MRI scans were obtained, and regional cortical thickness and surface area measurements were 
analyzed for relationships with test scores from 6 neurocognitive domains.  
In the combined sample, cortical thickness in the right rostral anterior cingulate was inversely 
related to working memory, and cortical surface area in four frontal and temporal regions were 
positively related to neurocognitive functioning. A positive relationship between left transverse 
temporal thickness and processing speed was specific to schizophrenia. A negative relationship 
between right temporal pole thickness and working memory was specific to bipolar disorder. 
In conclusion, significant cortical structure/function relationships were found in a large sample of 
healthy controls and patients with schizophrenia or bipolar disorder. The differences that were 
found between schizophrenia and bipolar may indicate differential relationship patterns in the two 
disorders, which may be of relevance for understanding the underlying pathophysiology. 
 
Keywords: MRI, neuropsychological tests, cerebral cortex, brain structure, cognition 
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1. Introduction  
In schizophrenia, there is substantial evidence for widespread cortical structure abnormalities such 
as cortical volume reduction (Arnone et al., 2009;Ellison-Wright and Bullmore, 2010;Glahn et al., 
2008) as well as frontotemporal cortical thinning (Nesvag et al., 2008) as measured with magnetic 
resonance imaging (MRI). Moreover, cortical surface area reductions have been demonstrated in 
adolescent-onset (Voets et al., 2008) and first-episode (Gutierrez-Galve et al., 2010) psychosis 
patients. For bipolar disorder, results have been more heterogeneous, but recent meta-analyses in 
bipolar patients have summarized that cortical grey matter reduction in the anterior cingulate and 
fronto-insular regions are characteristic features (Bora et al., 2010;Ellison-Wright and Bullmore, 
2010). Schizophrenia and bipolar disorder are classified as separate disorders, but overlapping 
clinical and neurocognitive features (Barch, 2009) as well as commonalities in genetic disposition 
(Lichtenstein et al., 2009) suggest a shared pathophysiology. Our research group recently 
demonstrated that cortical thinning in the frontal lobe appear common to schizophrenia and bipolar 
type 1 disorder (Rimol et al., 2010).  
 
Neurocognitive dysfunction has consistently been demonstrated in schizophrenia (Rund et al., 
2006) and to some extent in bipolar disorder (Bora et al., 2009), and is recognized as a possible 
intermediate phenotype and predictor of functional outcome (Green, 2006). Comparisons of 
cognitive performance across schizophrenia and bipolar disorder suggest that the differences 
between the patient groups are quantitative rather than qualitative, since the neurocognitive 
profiles are largely similar between the disorders (Jabben et al., 2010) although the magnitude of 
change is greater in schizophrenia. The similarities in neurocognitive profiles may suggest common 
underlying brain pathology (Lewandowski et al., 2011).  
 
Generally, specific cortical brain structures have been related with specific neurocognitive function 
in MRI-based studies with healthy adults (Dickerson et al., 2008;Fornito et al., 2004;Gur et al., 
1998;Sanfilipo et al., 2002;Walhovd et al., 2006) as well as dysfunction in individuals with focal 
brain lesions (Stuss et al., 2001a;Stuss et al., 2001b). In schizophrenia patients, performance on 
specific neurocognitive tests has been related to regional brain cortical volumes (Antonova et al., 
2005;Bonilha et al., 2008;Matsui et al., 2008;Minatogawa-Chang et al., 2009;Rusch et al., 2007;Wolf 
et al., 2008). The most consistent findings are positive relationships between frontal cortical 
volumes and executive functioning and with verbal memory. Only a few studies have investigated 
structure/function relationships in bipolar disorder (Bearden et al., 2001). In one study, subregional 
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volumes of the anterior cingulate were differently related to executive functioning in bipolar 
patients and healthy controls (Zimmerman et al., 2006b). Since volume is the product of thickness 
and surface area, the ability to separately study these two cortical characteristics enhances the 
opportunity of revealing even more specific relationships between cortical anatomy and cognitive 
abilities. 
 
We have previously, in an independent sample of healthy subjects and chronic schizophrenia 
patients demonstrated that cortical thickness in localized frontal/temporal regions were positively 
related with verbal learning, verbal IQ and executive functioning (Hartberg et al., 2010). In this 
study, the relationships between temporal and occipital regions with verbal IQ appeared disrupted 
in schizophrenia. In a recent study, the investigators reported widespread cortical thinning in first-
episode schizophrenia (FES) patients compared to healthy controls, but only a weak correlation 
between total and parietal cortical thickness and measures of attention (Crespo-Facorro et al., 
2010). However, Crespo-Facorro et al only investigated relationships within the patient group and 
used only lobar measurements. 
 
Regional cortical surface area has been related to general cognitive function (IQ) and working 
memory in another study of FES patients (Gutierrez-Galve et al., 2010). Finally, only a few studies 
have compared cortical structure/function relationships across schizophrenia and bipolar disorder 
patients in order to determine illness-specificity. Minatogawa-Chang et al (2009) found the middle 
frontal gyrus volume to be related with a composite cognitive test score specifically in a first-
episode psychosis group, however, subdividing into schizophrenic and affective psychosis did not 
yield illness-specific relationships. 
 
Taken together, although frontal and temporal brain cortical abnormalities are suggestive of 
cognitive dysfunction in both disorders, findings from studies addressing structure/function 
relationships in schizophrenia are inconsistent and there is a paucity of studies on cortical surface 
area, and in bipolar disorder. Thus, it is still unclear if and how cortical structure is related to 
neurocognition in schizophrenia and bipolar disorder.  
 
The objective of the present study was to investigate how cortical thickness and surface area were 
related to cognitive performance in a large sample (n=430) of patients with schizophrenia or 
bipolar spectrum disorders, and healthy control subjects. The three diagnostic groups were 
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investigated combined for general relationships between brain structure and cognitive function as 
well as separately for specific relationships. We also aimed at clarifying differences in 
structure/function relationships between schizophrenia and bipolar disorder, which to our 
knowledge, has not been done using both cortical thickness and surface area before.  
 
2. Materials and methods  
Subjects 
All participants were recruited between 2003 and 2009 as part of an ongoing study on psychotic 
disorders, the Thematically Organized Psychosis (TOP) Research Study (Rimol et al., 2010) in 
Norway. Patients were inpatients and outpatients and were referred from psychiatric units from 
four major hospitals in the greater Oslo area. In order to ensure a representative control group, the 
healthy controls were randomly selected from statistical records from the same catchment area as 
the patient groups, and contacted by letter inviting them to participate. 
 
All participants gave informed consent to participation, and the study has been approved by the 
Regional Committee for Medical Research Ethics and the Norwegian Data Inspectorate. 
 
All subjects from the larger TOP study who had undergone both MRI scanning and 
neuropsychological testing were included in the current study, but were excluded if they met the 
following criteria: a history of hospitalized head injury, neurological disorder, IQ < 70 points, and 
age outside the range of 18-65 years. To assure valid neurocognitive test performance, all 
participants had to have Norwegian as their first language or have received their compulsory 
schooling in Norway and had to score 15 or above in the forced recognition trial in the California 
Verbal Learning Test (CVLT)-II (Delis et al., 2004), which is a measure of adequate test effort. All 
MRI scans were evaluated by a neuroradiologist, and excluded if significant pathology was present. 
 
Included in the statistical analyses were patients with schizophrenia (n = 117) or bipolar spectrum 
disorders (n = 121), and healthy controls (n = 192). The schizophrenia spectrum included patients 
with schizophrenia (n = 94), schizophreniform disorder (n = 7) and schizoaffective disorder (n = 
16), the bipolar disorder group included both bipolar type 1 disorder (n = 76) and bipolar type 2 
disorder (n = 45). In the following we will refer to schizophrenia spectrum as “schizophrenia” and 
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bipolar type 1 and 2 disorder as “bipolar disorder”. Age was defined as age at MRI scanning. Years of 
education were registered as years of schooling as reported by the subjects during the interview.  
 
The healthy control sample was evaluated by an interview of severe mental disorder symptoms and 
the Primary Care Evaluation of Mental Disorders (PRIME-MD) (Spitzer et al., 1994). Controls were 
excluded if they had a diagnosis of drug abuse/dependency the last three months or had used drugs 
within the last 2 weeks, if they or any of their first-degree relatives had a life time history of a severe 
psychiatric disorder, or if they had a history of medical problems thought to interfere with brain 
function. 
 
Clinical assessment 
Clinical assessment was carried out by trained physicians and clinical psychologists. Diagnosis was 
based on the Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) (First, 2002). 
Diagnostic interrater reliability was found satisfactory, with overall agreement for DSM-IV 
diagnostic categories of 82 % with  = 0.77 (95% CI: 0.60-0.94) (Birkenaes et al., 2007). Current 
positive and negative symptoms were rated using the Positive and Negative Syndrome Scale 
(PANSS) (Kay et al., 1987). Psychosocial functioning in patients was assessed with the Global 
Assessment of Functioning (GAF) scale, split version. Interrater reliability for PANSS and GAF has 
been found to be satisfactory (Engh et al., 2010). Data on current medication were derived from 
interviews and medical records and for standardization purposes converted into Defined Daily 
Doses according to the WHO guidelines (http://www.whocc.no/atcdd). 
 
In order to obtain a clinically representative sample, all patients were included regardless of illicit 
drug use, but substance abuse/dependency was diagnosed (SCID module E) if present. Nine of the 
patients with schizophrenia spectrum and five of the patients with bipolar disorder had either a 
current diagnosis of cannabis abuse or were in early partial remission.  
Demographic and clinical data are displayed in table 1. 
Neurocognitive assessment  
Psychologists who were trained in standardized neuropsychological testing carried out the 
neurocognitive assessments. A comprehensive test battery was administered in a fixed order. 
Handedness was determined by hand preference when writing. Premorbid IQ was estimated using 
the National Adult Reading Test – Norwegian version (Sundet and Vaskinn, 2008). For the present 
study, neurocognitive tests were included from the full test-battery if 1) they or near identical tests 
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had previously shown a relationship with brain cortical thickness in an independent study of 
chronic schizophrenia (Hartberg et al., 2010), or 2) had previously been found to differ between 
schizophrenia and bipolar disorder patients (Simonsen et al., 2011). In the Simonsen et al study, we 
used a subject sample that overlapped with the present, but all calculations were independently 
performed in the current sample, and previous test results were used only to guide the selection of 
tests.  
 
In total, six measures were selected (see table 2): Verbal learning was tested with the Total recall 
trial score (list A1 – A5) from the California Verbal Learning Test, Second edition (CVLT-II) (Delis et 
al., 2004). Processing speed was assessed with the Digit Symbol subtest from the Wechsler Adult 
Intelligence Scale, Third edition (WAIS-III) (Wechsler, 2003). Working memory was assessed with 
the Digit Span subtest (sum of forward and backward trials) from the WAIS-III (Wechsler, 2003). 
Interference control was tested with the Inhibition subtest from the Color-Word Interference Test 
(Delis-Kaplan Executive Function Scale, D-KEFS) (Delis et al., 2005). Set shifting was measured with 
the Category Switching subtest (correct scores) from the Verbal Fluency Test (D-KEFS) (Delis et al., 
2005). Both interference control and set-shifting are considered to be aspects of executive 
functioning. Verbal IQ was estimated with the Vocabulary subtest from the Wechsler Abbreviated 
Scale of Intelligence (WASI) (Wechsler, 2007).  
 
Manual-based age and gender (when indicated) adjusted scaled scores [(T-scores: 50±10) or (S-
scores: 10 ±30)] are reported. For raw scores, higher scores equal better performance on all 
measures except for the Color-Word Interference Test.  
Brain imaging 
 MR image acquisition 
All participants underwent MRI scanning on a 1.5T Siemens Magnetom Sonata scanner (Siemens 
Medical Solutions, Erlangen, Germany) equipped with a standard head coil. After a conventional 3-
plane localizer, two sagittal T1-weighted magnetization prepared rapid gradient echo (MPRAGE) 
volumes were acquired with the Siemens tfl3d1_ns pulse sequence (TE = 3.93 ms, TR = 2730 ms, TI 
= 1000 ms, flip angle = 7°; FOV = 24 cm, voxel size = 1.33 x 0.94 x 1 mm3, number of partitions = 
160). Acquisition parameters were optimized for increased grey/white matter image contrast. 
There was no scanner upgrade during the study period. 
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 MR image processing 
The image files in DICOM format were transferred to a Linux workstation for morphometric 
analysis. Images were corrected for non-linear warping caused by gradient coil non-linearities, 
using tools developed through the Morphometry Biomedical Informatics Research Network 
(mBIRN), and the two T1-weighted images were rigid body registered to each other (motion 
corrected) and subsequently averaged together to increase the signal to noise ratio. In order to 
measure surface area and thickness the FreeSurfer software was used for cortical surface 
reconstruction followed by a procedure to obtain a representation of the grey/white matter 
boundary and the cortical (pial) surface (Dale et al., 1999;Fischl and Dale, 2000). Next, manual 
corrections of topological defects were performed blinded to diagnostic group identity. The 
software enables surface division into 34 parcellated [regions-of-interest (ROI)] regions in each 
hemisphere which are neuroanatomically labeled (Desikan et al., 2006;Fischl et al., 2004). Cortical 
thickness was calculated as the average distance between the grey/white boundary and the pial 
surface within each ROI. Surface area was calculated as the sum of the areas of each tessellation 
falling within a given ROI; this was done in each subjects’ native space. ICV estimates were obtained 
from the automated procedure for volumetric measurements of brain structures implemented in 
Freesurfer (Buckner et al., 2004).  
Selection of brain regions to be used in the analysis 
For the current study, we selected 28 predefined cortical regions (Fig. 1) within all brain lobes, but 
predominantly from the frontal and temporal lobes. These regions have shown to be abnormal in 
schizophrenia or bipolar disorder in previous MRI studies (Arnone et al., 2009;Lyoo et al., 
2006;Nesvag et al., 2008) and were also comparable with those used in the similar study on cortical 
thickness/area and cognition in FES patients (Gutierrez-Galve et al., 2010).  
 Statistical analyses 
All analyses were performed in the statistical software SPSS 16.0. 
 
 Group differences in demographic, clinical, neurocognitive and brain structure measurements 
Demographic and clinical, and standardized neuropsychological variables were compared across 
groups using Student’s t-tests, chi-square analyses and analyses of variance (ANOVAs) followed by 
Tukey’s post-hoc tests. Neuropsychological test comparisons for a subject sample partly 
overlapping with the present have been published earlier (Simonsen et al., 2011), but were 
repeated for this particular sample with standardized test scores. Group comparisons of average 
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cortical thickness and surface area measurements from each of the predefined brain regions were 
analyzed using ANCOVAs.  
Structure/function relationships by regression analysis 
The main analyses of relationships between cortical measurements and neurocognitive function 
were conducted as follows. First, multiple stepwise linear regression analyses were performed for 
the combined sample and separately for each of the three subject groups (groupwise analyses). 
Each cortical measure was entered as the dependent variable. Age, sex (and diagnosis for the 
combined group analyses) and all six neurocognitive test scores (raw scores) were entered as 
independent variables. Separate analyses were performed for the left and right hemisphere and for 
thickness and area. Due to demographic differences between the diagnostic groups, all analyses 
were corrected for age and sex differences. 
Group differences in correlations between cortical thickness/area and neurocognition 
Next, in order to test for differences in relationships, partial correlation coefficients from the group-
wise regression analyses, selected at alpha = 0.01, were contrasted with the corresponding 
correlation coefficients from the other groups in a pairwise manner using Fisher z transformations. 
Sixteen regions in total were selected from the separate group analyses for pairwise between-group 
contrasts of correlation coefficients based on this criterion. This alpha level was chosen in order to 
identify putative structure/function relationships. To correct for multiple comparisons, a 
conservative Bonferroni correction was applied to both the main analyses and to the pairwise 
contrast analyses.  
Medication and duration of illness 
Possible confounding factors were investigated with duration of illness and antipsychotic DDD 
(both logarithmic transformed) as covariates for the two patient groups. Only those patients who 
were prescribed medication were included.  
Subgroup analysis 
All analyses were repeated with bipolar type 1 separately, and for the narrow schizophrenia group 
(including schizophrenia and schizophreniform disorder, and excluding schizoaffective disorder), 
and excluding patients with current cannabis abuse. All analyses were two-tailed.  
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3. Results 
Demographic and clinical characteristics 
The three diagnostic groups differed on demographic variables with regard to age, sex and ethnicity 
(table 1). The schizophrenia group had lower mean age and more males than the two other groups. 
The groups also differed on clinical variables as expected from diagnostic categories. There were no 
group differences in handedness, education, premorbid IQ or intracranial volume. The two patient 
groups did not differ with regard to age at onset of illness or duration of illness.  
Group differences in neurocognitive performance 
The groups differed overall on all neuropsychological measures (Table 2). The highest effect sizes 
were observed for tasks in processing speed and attention demanding set-shifting. The 
schizophrenia group performed worse than the bipolar group and the healthy controls on all test 
scores, while the bipolar group performed worse than healthy controls on the processing speed, 
interference control and set-shifting tasks.  
Group differences in cortical thickness and area 
Comparisons of cortical thickness and surface area of the 28 predefined cortex regions conducted 
across the three diagnostic subject groups are presented in supplemental tables (S1 and S2, 
respectively). The cortical thickness results parallel those reported by Rimol et al (2010). Thickness 
reduction was found in 11 frontal and temporal regions in both schizophrenia and bipolar disorder 
compared with healthy controls, and in two regions in schizophrenia compared with bipolar 
disorder. Cortical surface area was smaller in four regions in schizophrenia relative to bipolar 
disorder and healthy controls. Surface area was larger in the left superior frontal region and the 
right temporal pole in bipolar disorder relative to healthy controls and schizophrenia patients. 
Relationships between cortical thickness/area and neurocognition 
In the combined group, there was one significant cortical thickness relationship and four significant 
surface area relationships with neurocognitive performance (Fig.2). There were no overlapping 
relationships between area and thickness. Increased cortical thickness in the right rostral anterior 
cingulate was related to poorer working memory performance. A larger surface area was related to 
better neurocognitive performance for the relationships between left rostral anterior cingulate and 
right rostral middle frontal regions with working memory performance, between left caudal middle 
frontal region and processing speed, and between left fusiform region and verbal IQ. 
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The results (p < 0.01) for the groupwise analyses are displayed in Table 3. In the schizophrenia 
group, larger cortical thickness in the left transverse temporal region was significantly related to 
better processing speed performance. In the bipolar disorder group, larger cortical surface area in 
the left inferior temporal region was significantly related to better processing speed performance, 
whereas in the healthy control group, larger cortical surface area in the right caudal middle frontal 
and left fusiform regions was significantly related to poorer verbal learning (Table 3). 
Group differences in correlations between cortical thickness/area and neurocognition 
Results for the group comparisons between partial correlation coefficients (derived from the 
groupwise regression analyses), are displayed in Table 4. After correction for multiple testing, 8 of 
the contrasts remained statistically significant. There were three significantly different correlations 
between schizophrenia and bipolar disorder; between cortical thickness in the left pars opercularis 
and working memory, between the left transverse temporal region and processing speed and 
between the right temporal pole and working memory. The latter correlation also differentiated the 
bipolar disorder patients from the healthy control group. The schizophrenia group displayed 
positive correlations in all three regions, while the bipolar group correlations were negative. There 
were four significantly different correlations between schizophrenia and healthy controls in 
temporal lobe regions; between cortical thickness in the left middle and transverse temporal 
regions and the left temporal pole and processing speed, and between surface area in the left 
fusiform region and verbal learning. All four correlations were positive in the schizophrenia group, 
while they were all negative in the healthy control group. 
Medication, duration of illness and subgroup analyses 
The patterns of relationships in the narrow schizophrenia (excluding schizoaffective disorder) and 
in the bipolar disorder type 1 groups were essentially the same as in the schizophrenia and bipolar 
spectrum groups respectively. Overall, the strength of relationships in Table 3 remained essentially 
the same after controlling for duration of illness and antipsychotic medication, and when excluding 
patients with current cannabis abuse.  
4. Discussion 
This is the first study to investigate relationships between regional cortical thickness/area and 
neurocognitive performance and directly compare between patients with schizophrenia and bipolar 
disorder investigated with the same MRI scanner, post-processing methodology and neurocognitive 
test battery. We detected a limited number of significant cortical structure/function relationships; 
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five relationships were significant in the combined group of participants i.e. were found to be the 
same in all three groups, and one relationship was significant in each of the separate groups. 
Additionally, there were significant group differences in relationships; three specific relationships 
between regional cortical thickness/function were different in schizophrenia compared with bipolar 
disorder, of which the negative relationship between cortical thickness in the right temporal pole 
and working memory was specific to bipolar disorder, and the positive relationship between 
cortical thickness in the left transverse temporal region and processing speed was specific to 
schizophrenia. Cortical thickness in several temporal regions was differently related to processing 
speed in schizophrenia relative to healthy controls. One cortical surface area/function relationship 
in healthy controls was different from that in schizophrenia, but not from bipolar disorder patients. 
 
Common significant relationships between all three groups suggest that there are general 
relationships that are not disrupted by having a diagnosis of either schizophrenia or bipolar 
disorder. For the relationship between cortical thickness in the right rostral anterior cingulate (AC) 
and working memory, the correlation was strongest in the bipolar disorder group, which is in 
accordance with the negative, but non-significant correlation between rostral AC grey matter 
volumes and measures of working memory that was previously demonstrated in bipolar disorder 
patients and healthy controls (Zimmerman et al., 2006b). The rostral AC has been related to 
emotional processes (Devinsky et al., 1995) known to be of importance in bipolar disorder, as well 
as implicated in circuitries disrupted in schizophrenia (Benes, 2010). The present results suggest 
that structural integrity in this region is related to working memory, regardless of group status. The 
results for frontal surface area relationships in the combined group are supported by the previous 
findings in FES patients (Gutierrez-Galve et al., 2010), however in Gutierrez-Galve et al study, there 
were significant relationships in the patient group only and not in controls. 
 
Although the present correlations between regional cortical thickness and working memory and 
processing speed are of small/medium effect sizes (Cohen, 1988), they are, as shown in the pair 
wise contrast analyses, in opposite directions in the schizophrenia and bipolar disorder patients, 
which suggest different patterns of relationships. Consistent with this, post-mortem studies 
demonstrate cellular differences in some, but not all regions of the frontal lobe between 
schizophrenia and bipolar patient groups (Selemon and Rajkowska, 2003).  
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Interestingly, several frontal and temporal brain regions showed diagnostic group interactions 
between schizophrenia and healthy controls for the relationship between cortical thickness and 
processing speed. Processing speed, which has been proposed to represent a more generalized 
cognitive feature underlying other speed-dependent cognitive tasks (Dickinson et al., 2007), has 
previously been related to widespread brain regions (Sanfilipo et al., 2002).  
 
We have previously demonstrated that a positive relationship between cortical thickness in the 
right fusiform (temporo-occipital) region and Verbal IQ in healthy controls were disrupted in 
chronic schizophrenia (Hartberg et al., 2010) which suggested that this region might be of special 
importance in the disorder. However, in the present study cortical area in the left fusiform region 
was significantly correlated with verbal learning in the healthy control group and, as shown in the 
pairwise contrast analysis, differentiated between healthy control group and the schizophrenia 
patients.  
 
How altered brain structure as found in the severe psychotic diseases such as schizophrenia or 
bipolar disorder relate to the impaired cognition is not known, but abnormal regional neuronal 
organization or density (Fornito et al., 2009;Selemon, 2001) has been proposed as factors. Cortical 
thickness and surface area have been shown to be genetically unrelated (Panizzon et al., 2009) and 
may represent different underlying cellular organization (Rakic, 1988) and hence relate differently 
to neurocognitive test scores. This assumption finds support in the present study, where regions of 
significant relationships between neurocognition and area and neurocognition and thickness did 
not overlap. Furthermore, there were more differences in relationships between subject groups for 
thickness than for area. Cortical thickness demonstrate variable regional heritability (Kremen et al., 
2010) and may be sensitive to environmental influences such as drug use (Habets et al., 2010), and 
illness-related factors (Goldman et al., 2009). We therefore corrected for cannabis abuse, illness 
duration and medication use in the analyses and our interpretation is that the present differences in 
cortical thickness relationships between subject groups reflect pathophysiological processes 
inherent to the disorders and not environmental. Although environmental effects on cortical surface 
area development cannot be excluded (White et al., 2002), surface area is mainly determined during 
embryonic and neonatal life without undergoing major subsequent changes (Rakic, 1988), and as 
such represents a window for investigating early neurodevelopmental disturbances. Reduced 
regional surface area (Table S2) and the disrupted relationship with verbal learning in 
14 
 
schizophrenia, but not in bipolar disorder, support theories of more severe neurodevelopmental 
disturbances in schizophrenia than in bipolar disorder.  
 
From our previous report on cortical thickness relationships with cognitive performance in chronic 
schizophrenia (Hartberg et al., 2010), we expected more widespread cortical thickness relationships 
in the present study. The patients who participated in the present study had been ill for a relatively 
short period of time (Table 1) as compared to other chronic patient cohorts, and in this regard were 
similar to the subjects in two studies on FES patients (Crespo-Facorro et al., 2010;Gutierrez-Galve et 
al., 2010). Both FES studies reported sparse results for relationships between cortical structure and 
specific neurocognitive domains. Also, the effect sizes for group differences in cortical thickness and 
neurocognitive performance were smaller in the present study (Table S1, Table 2) than in those 
with chronic patients (Heinrichs and Zakzanis, 1998;Nesvag et al., 2008), which might have limited 
our ability to detect subtle relationships. Furthermore, direct comparisons of younger with older 
(above approximately 40 years) adults have revealed stronger and positive relationships in the 
older subjects (Zimmerman et al., 2006a) regardless of having a schizophrenia diagnosis or not 
(Premkumar et al., 2008), suggesting that structure/function relationships generally become more 
pronounced with higher age. Also, there may be non-linear effects of age or a dynamic age-
dependent interplay between structure and function, which makes the relationships change over 
time and difficult to detect in cross-sectional studies. An example of this would be the demonstrated 
progression of grey matter loss concurrent with neurocognitive improvements in the first years 
after illness onset in schizophrenia (Zipparo et al., 2008). 
 
There were a few limitations to this study. The group differences in age and sex may have affected 
the results although they were statistically corrected for in all statistical analyses. In order to give an 
account of the pattern of relationships in each group, separate group analyses were conducted 
which resulted in a large number of statistical tests. Because of this, the results must be interpreted 
with some caution. However, the threshold for selection of groupwise relationships for further 
group comparisons are in accordance with the threshold used by other researchers in the field, and 
furthermore, a conservative multiple comparison control (Bonferroni) was applied to the final 
results. Lastly, it has been reported that use of medication can affect cortical structure (Navari and 
Dazzan, 2009). In our analyses, we corrected for the current dose of antipsychotic medication, 
which was found not to affect the results. Only a few subjects (n=17) were prescribed Lithium, and 
thus the effect of Lithium on cortical structure could not be investigated.  
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In conclusion, in the present sample of healthy controls and patients with schizophrenia or bipolar 
disorder, we find significant relationships between regional cortical thickness or surface area and 
neurocognitive test scores, of which some are common to all groups and other are unique to 
schizophrenia or bipolar disorder. Different patterns of structure/function relationships between 
schizophrenia and bipolar disorder suggest differences in underlying pathophysiology, but whether 
these patterns are consistent should be tested in independent samples. Future longitudinal studies 
are needed to determine how structure and function interrelate over time.  
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Figure 1. 
 
Lateral and midsagittal views of the selected parcellations. AC, Anterior cingulate.  
 
 
27 
 
Figure 2. Relationships in the combined sample 
 
Scatter plots showing significant relationships between cortical thickness (mm) and cortical 
surface area (mm2) with neurocognitive performance, adjusted for age and sex in the combined 
sample.  A) Larger cortical thickness in the right rostral anterior cingulate related to poorer 
working memory performance (B = 0.17, p = 0.0004), B) larger cortical surface area in the left 
rostral anterior cingulate related to better working memory performance (B = 0.14 , p = 0.003 ), 
C) larger cortical surface area in the right rostral middle frontal region related to better working 
memory performance (B = 0.14, p = 0.001 ) D) larger cortical surface area in the left caudal 
middle frontal region related to better processing speed performance (B = 0.15, p = 0.003), E) 
larger cortical surface area in the left fusiform region related to better verbal IQ (B = 0.14, p = 
0.002)  
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Abstract:  
Background: Similar patterns of subcortical brain abnormalities as well as neurocognitive 
dysfunction profiles have been demonstrated in schizophrenia and bipolar disorder, with more 
extensive findings in schizophrenia. It is not known whether relationships between subcortical 
brain volumes and neurocognitive performance are similar in these diseases or if there are illness-
specific differences in schizophrenia as compared with bipolar disorder and healthy controls. 
Methods: Magnetic Resonance Imaging scans and neuropsychological test performance were 
obtained from patients with schizophrenia (n = 117) or bipolar spectrum disorder (n = 121) and 
healthy control subjects (n = 192). Using the FreeSurfer software, volumes of 18 selected 
subcortical structures were automatically segmented and analyzed for relationships with 7 
neurocognitive test scores for all subjects combined, and in separate groupwise analyses. 
Relationships from the separate group analyses were compared across groups. 
Results: In the combined group, larger left inferior lateral ventricle volumes were related to poorer 
motor speed performance, larger right hippocampus volumes were related to poorer working 
memory, and larger bilateral putamen volumes were related to poorer verbal learning. The 
negative relationship between right putamen volume and set-shifting found in schizophrenia and 
bipolar disorder was found to be reversed in healthy controls. A negative relationship between left 
putamen with working memory was specific to schizophrenia. 
Conclusion: The present findings suggest that there are similarities as well as differences in 
subcortical structure/function relationships between patients with schizophrenia or bipolar 
disorder and healthy individuals. More specifically, putamen may be of importance to 
neurocognitive dysfunction in these disorders. 
 
Keywords: MRI, putamen, working memory, hippocampus, ventricles 
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1. Introduction  
Cognitive functioning has traditionally been related to the neocortical parts of the brain. Brain 
lesion studies have demonstrated that there are, to some extent, associations between localized 
cortical lesions and cognitive dysfunction such as impairment of attention and executive 
functioning (Stuss et al., 2000;Stuss et al., 2001). Magnetic Resonance Imaging (MRI) based 
investigations have demonstrated relationships between cortical volumes (Gur et al., 
2000a;Sanfilipo et al., 2002) and cortical thickness (Hartberg et al., 2010;Tamnes et al., 
2010;Walhovd et al., 2006), and specific neurocognitive test scores in healthy subjects. 
 
Current views in neuroscience support the notion that cognitive functioning rely on neural 
distributed networks (Middleton and Strick, 2000b), which include subcortical structures, that 
work in parallel circuits. The prefrontal and temporal cortical areas are anatomically linked directly 
or indirectly, via the thalamic nuclei, with the basal ganglia structures (putamen and caudate nuclei 
and globus pallidum) (Groenewegen et al., 1997;Middleton and Strick, 2000b), the cerebellar 
cortices (Strick et al., 2009), and the hippocampus and amygdala (Groenewegen et al., 1997). It is 
increasingly recognized that the basal ganglia and the cerebellum influence or modulate cognitive 
behavior (Casey, 2005;Koziol and Budding, 2009) in addition to motor behavior. Neuronal circuits 
underlying cognitive control may be disturbed in neurodevelopmental diseases (Casey, 2005), such 
as schizophrenia (Rapoport et al., 2005) and possibly also in bipolar disorder (Sanches et al., 2008). 
In these diseases, projections between the cortex and the subcortical structures might undergo 
abnormal changes such as enhancement of some projections while others are eliminated through 
childhood and adolescent neurodevelopment, thus result in disrupted connectivity between crucial 
networks (Kyriakopoulos and Frangou, 2009;White et al., 2007). Hypothetically, these changes 
could be reflected in altered subcortical volumes and, consequently, result in abnormal 
subcortical/cognitive function relationships.  
 
Previous scientific research on schizophrenia and bipolar patients has demonstrated subcortical 
structural abnormalities that co-occur with widespread cortical volume reduction (Arnone et al., 
2009). The most consistent findings are enlarged lateral ventricles (Arnone et al., 2009) and 
reduced hippocampal and amygdala volumes in both disorders (Blumberg et al., 2003;Honea et al., 
2005), and smaller thalamic volumes as well as enlarged striatal structure volumes in 
schizophrenia (Ellison-Wright and Bullmore, 2010). It is under debate whether the striatal 
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enlargements are related to illness duration, antipsychotic (AP) medication or to other illness-
related factors (Brandt and Bonelli, 2008;Navari and Dazzan, 2009). Also, widespread age-related 
subcortical volume changes have been demonstrated in healthy subjects (Walhovd et al., 2009), 
thus individual differences in age should be corrected for. 
 
We recently demonstrated similar subcortical abnormalities across schizophrenia and bipolar 
disorder as compared to healthy controls (Rimol et al., 2010); enlarged lateral and inferior 
ventricles, reduced bilateral hippocampi, cerebellar cortices and left thalamus, albeit larger 
differences (effect sizes) were detected in schizophrenia than in bipolar disorder as compared to 
healthy controls. Right putamen was significantly larger in schizophrenia than in bipolar disorder, 
and there were trends for larger left putamen and bilateral pallidum volumes as well. Current AP 
medication or illness duration did not significantly affect the results. Likewise, neurocognitive 
dysfunction is present in both schizophrenia and bipolar disorder. Comparisons across patient 
groups result in similar neurocognitive profiles, but the degree of cognitive impairment is worse in 
schizophrenia compared with bipolar disorder (Barch, 2009). 
 
In schizophrenia, subcortical structure/function relationships have been demonstrated between 
hippocampal, amygdala (Goldberg et al., 1994;Gur et al., 2000b;Killgore et al., 2009) and cerebellar 
volumes (Toulopoulou et al., 2004), and memory measures. Striatal (Mamah et al., 2007;Stratta et 
al., 1997) and thalamic (Crespo-Facorro et al., 2007b) volumes have been related to executive 
functioning and attention. Caudate volumes have been related to motor speed (Hokama et al., 
1995), while putamen volume has been related to verbal learning (Lawyer et al., 2006). Ventricular 
size has been related to executive functioning and visuomotor speed and verbal IQ (Lawyer et al., 
2006). Some investigators have reported no findings (Antonova et al., 2005;Crespo-Facorro et al., 
2007a;DeLisi et al., 1991). Only a few studies have addressed such relationships in bipolar disorder 
patients; hippocampal volume has been related to measures of attention (Sax et al., 1999), verbal 
fluency and verbal working memory (Ali et al., 2000), while others have found no relationships 
(Haldane et al., 2008). The majority of such studies have focused on single or few subcortical 
structures, and none of them made direct comparisons with other patient groups. 
 
To our knowledge, only one study has directly compared subcortical structure/function 
relationships in schizophrenia with those in bipolar disorder. Killgore et.al (2009) demonstrated 
opposite relationships between amygdala volumes and memory performance in schizophrenia and 
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bipolar disorder. However, they limited their analyses to the hippocampus and amygdala and 
measures of verbal memory, and used a relatively small subject sample (n=30).  
 
Thus, how an extensive range of subcortical structure volumes relate to neurocognitive function 
across schizophrenia and bipolar disorder and healthy controls remain unanswered. We used the 
Freesurfer software which performs automatic segmentation of subcortical brain structures, in 
contrast with manual delineation, allowing for measurement of a large range of subcortical 
structure volumes, of which we selected 18 of interest, in a large subject sample (n=430), 
comprising patients with schizophrenia or bipolar disorder, and healthy controls. 
Neuropsychological tests from seven domains were investigated in relation to the subcortical 
volumes and the relationships were directly compared across the three groups. Given the effect that 
antipsychotic medication may have on striatal structures, confounding effects of medication in our 
analyses were given special attention. 
2. Materials and methods 
2.1 Participants 
All participants were recruited between 2003 and 2009 as part of an ongoing study on psychotic 
disorders Thematically Organized Psychosis (TOP) Research Study (Rimol et al., 2010) in Norway. 
Patients were inpatients and outpatients and were referred from psychiatric units from four major 
hospitals in the greater Oslo area. In order to ensure a representative control group, the controls 
were randomly selected from statistical records from the same catchment area as the patient 
groups, and contacted by letter inviting them to participate. All participants gave informed consent 
to participation, and the study has been approved by the Regional Committee for Medical Research 
Ethics and the Norwegian Data Inspectorate.  
 
All subjects from the larger TOP study who had undergone both MRI scanning and 
neuropsychological testing were included in the current study, but were excluded if they met the 
following criteria: a history of hospitalized head injury, neurological disorder, IQ < 70 points, and 
age outside the range of 18-65 years. To assure valid neurocognitive test performance, all 
participants had to have Norwegian as their first language or have received their compulsory 
schooling in Norway, and had to score 15 or above on the forced recognition trial of the California 
Verbal Learning Test (CVLT)-II (Delis et al., 2004), which is a measure of adequate test effort. All 
MRI scans were evaluated by a neuroradiologist, and excluded if significant pathology was present.  
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Included in the statistical analyses were 117 patients with schizophrenia spectrum disorders, 121 
patients with bipolar spectrum disorders, and 192 healthy control subjects. The schizophrenia 
spectrum included patients with schizophrenia (n = 94), schizophreniform disorder (n = 7) and 
schizoaffective disorder (n = 16), the bipolar disorder group included both bipolar type 1 disorder 
(n = 76) and bipolar type 2 disorder (n = 45). In the following we will refer to schizophrenia 
spectrum as “schizophrenia” and bipolar type 1 and 2 disorder as “bipolar disorder”. Age was 
defined as age at MRI scanning. Years of education were registered as years of schooling as 
reported by the subjects during interview.  
 
The healthy control sample was evaluated by a clinical interview of severe mental disorder 
symptoms and the Primary Care Evaluation of Mental Disorders (PRIME-MD) (Spitzer et al., 1994). 
Controls were excluded if they had a diagnosis of drug abuse/dependency the last three months or 
had used drugs within the last 2 weeks, if they or any of their first-degree relatives had a lifetime 
history of a severe psychiatric disorder (schizophrenia spectrum disorders, bipolar disorder or 
major depression), or if they had a history of medical problems thought to interfere with brain 
function (uncontrolled hypertension, inadequately treated hypothyroidism or diabetes). 
 
Trained physicians and clinical psychologists performed the clinical assessments. Diagnosis was 
based on the Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) (First, 2002). 
Diagnostic interrater reliability was found satisfactory, with overall agreement for DSM-IV 
diagnostic categories of 82 % with  = 0.77 (95% CI: 0.60-0.94) (Birkenaes et al., 2007). Current 
positive and negative symptoms were rated using the Positive and Negative Syndrome Scale 
(PANSS) (Kay et al., 1987). Psychosocial functioning in patients was assessed with the Global 
Assessment of Functioning (GAF) scale, split version. Interrater reliability for PANSS and GAF has 
been found to be satisfactory (Engh et al., 2010). Data on current medication were derived from 
interviews and medical records. In order to obtain a clinically representative sample, all patients 
were included regardless of drug use, but abuse/dependency was diagnosed (SCID module E) if 
present. Nine of the patients with schizophrenia spectrum and five of the patients with bipolar 
disorder had either a current diagnosis of cannabis abuse or were in early partial remission. 
Demographic and clinical data are displayed in Table 1. 
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2.2 Neurocognitive assessment 
Psychologists trained in standardized neuropsychological testing performed the neurocognitive 
assessments. A comprehensive test battery was administered in a fixed order. Handedness was 
determined by hand preference when writing. Premorbid IQ was estimated using the National 
Adult Reading Test – Norwegian version (Sundet and Vaskinn, 2008). For the present study, 
neurocognitive tests were included from the full test-battery if 1) they or near identical tests had 
previously shown a relationship with brain cortical thickness in an independent study of chronic 
schizophrenia (Hartberg et al., 2010), or 2) had previously been found to differ between 
schizophrenia and bipolar disorder patients in an overlapping sample with the present (Simonsen 
et al., 2011). In addition, given the relationship between basal ganglia and motor control, a measure 
of motor speed was included. In total, 7 neurocognitive function measures were selected: Verbal 
learning was tested with the Total recall trial score (list A1 – A5) from the California Verbal 
Learning Test, Second edition (CVLT-II) (Delis et al., 2004). Motor speed was measured with the 
dominant hand scores from the Grooved Pegboard Test (Klove, 1963). Processing speed was 
assessed with the Digit Symbol subtest from the Wechsler Adult Intelligence Scale, Third edition 
(WAIS-III) (Wechsler, 2003). Working memory was assessed with the Digit Span subtest (sum of 
forward and backward trials) from the WAIS-III (Wechsler, 2003). Interference control was tested 
with the Inhibition subtest from the Color-Word Interference Test (Delis-Kaplan Executive 
Function Scale, D-KEFS) (Delis et al., 2005). Set-shifting was measured with the Category Switching 
subtest (correct scores) from the Verbal Fluency Test (D-KEFS) (Delis et al., 2005). Both 
interference control and set-shifting are considered to be aspects of executive functioning. Verbal 
IQ was estimated with the Vocabulary subtest from the Wechsler Abbreviated Scale of Intelligence 
(WASI) (Wechsler, 2007). Raw scores were used in the main analyses, for which higher scores 
equal better performance on all measures except for the Color-Word Interference Test and the 
Grooved Pegboard Test for which higher scores equal poorer performance.  
2.3 Brain imaging 
2.3.1 MR image acquisition 
All participants underwent MRI scanning on a 1.5T Siemens Magnetom Sonata scanner (Siemens 
Medical Solutions, Erlangen, Germany) equipped with a standard head coil. After a conventional 3-
plane localizer, two sagittal T1-weighted magnetization prepared rapid gradient echo (MPRAGE) 
volumes were acquired with the Siemens tfl3d1_ns pulse sequence (TE = 3.93 ms, TR = 2730 ms, TI 
= 1000 ms, flip angle = 7°; FOV = 24 cm, voxel size = 1.33 x 0.94 x 1 mm3, number of partitions = 
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160). Acquisition parameters were optimized for increased grey/white matter image contrast. 
There was no scanner upgrade during the study period. 
2.3.2 MR image processing 
The image files in DICOM format were transferred to a Linux workstation for morphometric 
analysis. Images were corrected for non-linear warping caused by gradient coil non-linearities, 
using tools developed through the Morphometry Biomedical Informatics Research Network 
(mBIRN) (Fennema-Notestine et al., 2007), and the two T1-weighted images were rigid body 
registered to each other (motion corrected) and subsequently averaged together to increase the 
signal to noise ratio. Subcortical volumes were obtained from the automated procedure for 
volumetric measures of brain structures implemented in Freesurfer (Fischl et al., 2002) as well as 
intracranial volume (ICV) estimates (Buckner et al., 2004). Next, manual corrections of topological 
defects were performed blinded to diagnostic group identity. In addition to ICV, nine measures 
from each hemisphere (18 in total) were chosen for the investigations; the lateral ventricles, the 
inferior lateral ventricles, hippocampus, amygdala, thalamus, pallidum, putamen, caudate, and the 
cerebellar cortex (Fig. 1).  
2.4 Statistical analyses 
All analyses were performed with the statistical software program SPSS 16.0. 
2.4.1 Group differences in demographic, clinical, neurocognitive and subcortical volume variables 
Demographic and clinical as well as age and sex-adjusted neuropsychological variables 
(standardized scores) were compared across groups using Student’s t-tests, chi-square analyses 
and analyses of variance (ANOVAs) followed by Tukey’s post-hoc tests. Group comparisons of 
subcortical volumes were done using ANCOVAs with age and ICV as covariates. Group comparisons 
of subcortical volumes have been published earlier by our research group for a larger, but 
completely overlapping subject sample (Rimol et al., 2010). 
2.4.2 Regression analysis 
The main analyses of relationships between subcortical volumes and neurocognitive function were 
conducted as follows. First, stepwise linear regression analyses were performed for the combined 
sample, then within each subject group (groupwise analysis). The subcortical measures in the left 
and right hemisphere, respectively, were entered as dependent variables. Age and ICV (and 
diagnosis for the combined group analyses) and all seven neurocognitive test scores were entered 
as independent variables, and were checked for collinearity. Preliminary analyses with sex as a 
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covariate were conducted but sex differences did not affect the results, and was therefore not 
included in the main analyses. 
2.4.3 Group differences in correlations between subcortical volumes and neurocognition 
Next, in order to test for differences in relationships, partial correlation coefficients from the group-
wise regression analyses selected at alpha = 0.01, were tested for difference with the corresponding 
correlation coefficients from the other groups in a pairwise manner using Fisher z transformations. 
Thirteen subcortical structure volumes in total were selected from the separate group analyses for 
pairwise between-group contrasts. Bonferroni corrections were applied to the main analyses and to 
the pairwise contrasts.  
2.4.4 Medication and duration of illness 
Subsequent to the main analyses, the results in the patient groups were investigated for the 
potential effects of confounding factors; all analyses were repeated with logarithmic transformed 
duration of illness and antipsychotic DDD (Table 1), and estimated total lifetime exposure of AP 
medication (current antipsychotic DDD x illness duration) as covariates. Only subjects who were 
prescribed AP medication (Table 1) were included in the medication analyses. Medication as 
confounding factor was also explored by including only those who were using atypical AP 
medication in the analyses. The patients who were medication free or only used typical APs (Table 
1) were too few to be investigated as separate groups.  
2.4.5 Subgroup analysis 
All analyses were repeated for bipolar disorder type 1 separately, and for the narrow schizophrenia 
group (schizophrenia and schizophreniform but excluding schizoaffective disorder), and finally 
excluding patients with current cannabis abuse. All analyses were two-tailed.   
3. Results 
3.1 Demographics and clinical characteristics 
The groups differed on demographic variables with regard to age, sex and ethnicity, and on clinical 
variables as expected from diagnostic categories (Table 1). The schizophrenia group had lower 
mean age and more males than the two other groups. There were no overall group differences in 
handedness, education or premorbid IQ; or in age at onset of illness and duration of illness between 
the patient groups.  
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3.2 Group differences in neurocognition and subcortical volumes 
The groups differed overall on all neuropsychological measures (Table S1). The highest effect sizes 
were observed for processing speed and set-shifting. The schizophrenia group performed worse 
than the bipolar group and the healthy controls on all tests, except for motor speed, on which both 
patient groups performed worse than the healthy control group. The bipolar group performed 
worse than healthy controls on the processing speed, interference control and set-shifting tasks. 
 
Intracranial volumes did not significantly differ across groups (Table S2). The results from the 
subcortical group comparisons parallel those from a previous publication of mainly overlapping 
sample (Rimol et al., 2010); schizophrenia and bipolar patients exhibited larger ventricles, smaller 
bilateral hippocampi and left thalamus than the healthy controls, whereas the right putamen was 
larger in schizophrenia patients than in bipolar disorder patients and healthy controls, and the left 
cerebellar cortex was smaller in bipolar patients compared to healthy controls (Table S2).  
3.3 Relationships between subcortical volumes and neurocognition 
In the combined sample, four significant relationships were found (Fig. 2); a larger left inferior 
lateral ventricle was related to poorer motor speed performance; bilateral larger putamen volumes 
were related to poorer verbal learning performance, and a larger right hippocampus was related to 
poorer working memory performance. A trend-level relationship in the same direction was also 
observed for left hippocampus volume and working memory (p = 0.01).  
 
The results from the groupwise analyses (p < 0.01) are presented in Table 2. Significant 
relationships in the schizophrenia group were found between larger left inferior lateral ventricles 
and poorer motor speed performance, and between larger bilateral putamen volumes and poorer 
performance on verbal learning, working memory and set-shifting, and between larger left 
putamen volume and poorer interference control. In the bipolar disorder group, larger left lateral 
and inferior lateral ventricle volumes were significantly related to poorer motor speed 
performance, and larger inferior lateral ventricle was related to poorer interference control. No 
relationships were found in the healthy control group or for any of the other structures. 
3.4 Group differences in correlations between subcortical volumes and neurocognition 
The results from the group comparisons are displayed in Table 3. After correction for multiple 
testing, 9 of the contrasts were statistically significant. The correlations between the left inferior 
lateral ventricle volume and motor speed performance, and between putamen volumes (significant 
 12
for the right, trend for the left) and set-shifting, were similar in schizophrenia and bipolar disorder 
and significantly different from healthy controls. The correlations between bilateral putamen 
volumes and working memory were significantly different in schizophrenia patients as compared 
to healthy controls. The negative correlation between left putamen and working memory also 
differentiated the schizophrenia patients from the bipolar disorder patients, who displayed a 
positive correlation, and thus appears specific to schizophrenia. The same pattern of relationships 
were observed for the right putamen, albeit not significantly. The relationship between the left 
inferior lateral ventricle and interference control in the bipolar disorder group was different from 
that in healthy controls, but not from that in the schizophrenia group, thus no relationship was 
specific to the bipolar disorder group. 
3.5 Medication and duration of illness  
Co-varying for illness duration, current and lifetime exposure of antipsychotic medication, and 
investigating those patients using atypical medication separately, did not affect the results shown in 
Table 2. When controlling for medication effects there was one exception; left lateral ventricular 
size and processing speed in the bipolar disorder patient group was no longer related. However, all 
the other relationships in the bipolar group displayed in Table 2, resulted in higher correlation 
coefficients (r = 0.33 – 0.47) when medication, but not illness duration, was corrected for.  
3.6 Subgroup analyses 
The bipolar disorder type 1 and the narrow schizophrenia groups displayed similar results as the 
whole bipolar and schizophrenia groups, respectively. The exclusion of current cannabis abusers in 
the analyses did not affect the results.  
4. Discussion 
This is the first comprehensive study of relationships between subcortical structure volumes and 
neurocognitive functioning in schizophrenia, bipolar disorder and healthy controls. In addition, the 
relationships were directly compared across the three groups. We demonstrate four significant 
subcortical structure/function relationships in the combined sample, one additional relationship 
that was exclusive to schizophrenia and bipolar disorder, and another that was specific to 
schizophrenia. In the combined sample, larger left inferior lateral ventricle volumes were related to 
poorer motor speed performance, larger right hippocampus volumes were related to poorer 
working memory performance and larger left and right side putamen volumes were both related to 
poorer verbal learning. In schizophrenia and bipolar disorder, larger right putamen volumes were 
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related to poorer set-shifting performance, while the inverse relationship was found in healthy 
controls. The relationship between larger left putamen volume and poorer working memory 
performance was specific to schizophrenia.  
 
The findings were essentially unchanged when co-varying for AP medication or illness duration. 
However, one interesting result emerged from the follow-up analyses in the bipolar disorder group; 
co-varying for AP medication effect, but not illness duration, resulted in stronger correlations 
between inferior lateral and lateral ventricular sizes and motor speed, indicating that use of 
medication in this group affected the relationship magnitudes between the ventricles and motor 
speed. This effect was not specific to the bipolar disorder type 1 subgroup, but may be mediated by 
more severe symptomatology or occurrence of psychotic episodes in those who were prescribed 
antipsychotic medication across the bipolar disorder spectrum. 
 
To our knowledge, this is the first time ventricular volume size has been associated with motor 
speed performance. The relationships were the same in all groups but significantly stronger in both 
patients groups compared to the healthy control group. The inferior lateral ventricle, which is the 
temporal horn of the lateral ventricular system, borders with temporal lobe structures known to be 
smaller in schizophrenia and bipolar disorder (Blumberg et al., 2003;Honea et al., 2005;Rimol et al., 
2010), and with parts of the caudate nucleus, which volume has been related to motor speed. 
(Hokama et al., 1995). However, surrounding gray matter reductions cannot completely explain the 
extensive ventricular enlargements in severe mental diseases. Whether white matter abnormalities 
can explain the ventricular enlargement remains to be determined.  
 
The negative relationship between right hippocampus and working memory in the combined group 
is substantiated by previously reported findings in bipolar disorder (Ali et al., 2000) as well as in 
schizophrenia (Spoletini et al., 2011). Furthermore, functional MRI studies have shown 
hippocampal activity during working memory tasks in healthy individuals (Cabeza et al., 2002), 
suggesting hippocampal involvement in short-term memory networks as well as in long-term 
memory networks. The bilateral putamen volume relationships with verbal learning across all 
groups are in accordance with the findings by Lawyer et al. (Lawyer et al., 2006). We did not 
replicate the opposite relationships between amygdala volume and verbal memory in the patient 
groups that were shown by Killgore et al (2009).  
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Considering that the working memory task, and the interference control and set-shifting tasks 
selected for the present study measure aspects of attention and executive functioning, respectively, 
the present relationships with putamen in schizophrenia are supported by results from other 
studies in schizophrenia patients (Lawyer et al., 2006;Mamah et al., 2007;Stratta et al., 1997). 
However, by increasing the sample size and making direct comparisons between schizophrenia and 
bipolar disorder, we can show that the relationship with working memory was specific to 
schizophrenia; whereas the relationship with set-shifting performance was similar in the 
schizophrenia and bipolar disorder groups. Notably, in the present study, the bipolar patients were 
impaired on set-shifting performance, but not on working memory performance, while the 
schizophrenia patients were impaired on both tasks, compared to healthy controls. Larger putamen 
volumes have also been related to increased severity of positive symptoms in neuroleptic-naïve 
patients (Gur et al., 1998), and considering the present relationship with poorer neurocognitive 
functioning, putamen size may directly reflect the severity of clinical and neurocognitive 
dysfunctions observed in schizophrenia and bipolar disorder.  
 
Putamen, which is part of the dorsal striatum, is functionally and anatomically connected with other 
parts of the brain and participates in parallel loops, forming the so-called cortico-striatal-pallido-
thalamo-cortical circuitries. Several of the loops include prefrontal and temporal non-motor areas 
(Alexander et al., 1986;Middleton and Strick, 2000a). Thus, the differences in relationships between 
putamen and working memory and set-shifting in schizophrenia and bipolar disorder patients 
compared to healthy controls may be due not only to pathology directly related to putamen 
structure volumes, but also to any part of the several parallel loops involving the putamen. 
 
Elevated striatal dopamine levels have consistently been shown in schizophrenia patients (Howes 
and Kapur, 2009) and there is evidence that striatal dopaminergic abnormalities are linked with 
cognitive dysfunction (Simpson et al., 2010) in the disease. Of pathophysiological relevance to the 
present findings, Kellendonk et al (2006) performed a study on transgenic mice, that were 
overexpressing D2 receptors in the striatum, and showed that the mice exhibited selective deficits 
in working memory and flexibility compared with those with normal levels of dopamine, and that 
the deficits remained after the overexpression was switched off, thus suggesting that 
developmental changes caused the cognitive deficits. Furthermore, the striatal dopamine levels 
affected the level of prefrontal dopamine transmission; however, it is not known whether the 
cognitive dysfunction is primary or secondary to striatal dysfunction.  
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Limitations 
A limitation in this study is the possible confounding effect of antipsychotic medication. Several 
reviews have summarized the possible effects of APs on brain structure (Brandt and Bonelli, 
2008;Navari and Dazzan, 2009;Scherk and Falkai, 2006). In sum, they report that use of typical but 
not atypical APs is associated with basal ganglia enlargement, and that the effects are dynamic and 
reversible (Chakos et al., 1995;Lang et al., 2004). Due to the small number of drug free participants 
or patients using typical AP in the present study, separate analyses for these particular groups were 
not possible. However, current and total dose of APs, and only those with atypical APs were 
included in separate analyses, none of which changed the main results. Also, the similarity of 
relationships between putamen volumes and verbal learning across groups may indicate that our 
findings are not merely medication-related effects. Therefore, we suggest that the relationships 
between putamen and working memory, interference control and set-shifting are illness-related 
rather than consequences of AP treatment. However, replications in independent samples, 
preferably of drug naïve patients or from longitudinal studies are needed. 
Conclusion 
In addition to demonstrating several structure/function relationships that are similar between 
schizophrenia, bipolar disorder and healthy controls in the subcortical brain, the present study also 
shows that disrupted relationships specifically occur between putamen and neurocognitive 
performance in schizophrenia, and to some extent also in bipolar disorder as compared with 
healthy controls, indicating that putamen volumes are of importance to neurocognitive dysfunction 
in these disorders.  
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Table 3. Pairwise contrasts of correlations (p < 0.01) between subcortical volumes  
and neurocognitive tests. 
 
* Only correlations significant at alpha level = 0.01 (as shown in Table 2) were selected for further 
pairwise comparisons. Bold indicates significant group differences in correlation coefficients after 
Bonferroni correction. 
Abbreviations: CTR, Healthy control subjects; SCH, Schizophrenia; BD, Bipolar disorder; r, partial 
correlation coefficient; z, Fisher’s z value; L, left hemisphere; R, right hemisphere; dsp, Digit Span 
Total; dsy, Digit Symbol Test; int, Color-Word interference test; cvlt, California Verbal Learning test; 
ssh, Set Shifting Test; gpd, Grooved Pegboard. 
 
 
 Group relationships   Pairwise contrasts 
 SCH BD CTR CTR – SCH CTR – BD SCH - BD 
  r  z p z p z p 
Subcortical volume / test          
Lat ventricle L /gpd 0.02 0.30* 0.06 0.3 0.741 -2.2 0.029 -2.2 0.025 
Lat ventricle L / dsy 0.06 -0.24* 0.03 -0.3 0.803 2.4 0.017 2.4 0.018 
Inf lat ventricle L /gpd 0.31* 0.29* 0.02 -2.6 0.011 -2.4 0.016 0.2 0.873 
Inf lat ventricle L / int -0.01 0.26* -0.03 -0.2 0.865 -2.5 0.011 -2.1 0.034 
Cerebellar cortex L / gpd 0.24* 0.03 0.10 -1.2 0.234 0.7 0.497 1.7 0.093 
Putamen L / cvlt -0.26* -0.16 -0.05 1.8 0.072 1.0 0.342 -0.8 0.441 
Putamen R / cvlt  -0.28* -0.15 -0.06 1.9 0.062 0.7 0.465 -1.0 0.303 
Putamen L / dsp -0.28* 0.08 0.05 3.2 0.001 -0.3 0.795 -2.8 0.006 
Putamen R / dsp -0.27* -0.02 0.03 2.6 0.009 0.4 0.697 -2.0 0.043 
Putamen L / int 0.30* 0.00 0.08 -1.9 0.054 0.7 0.509 2.3 0.020 
Putamen R / int 0.25* 0.03 0.04 -1.8 0.066 0.1 0.928 1.7 0.082 
Putamen L / ssh -0.31* -0.20 0.08 3.4 0.001 2.4 0.017 -0.9 0.363 
Putamen R / ssh -0.27* -0.21 0.11 3.3 0.001 2.8 0.005 -0.5 0.624 
 25
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 Subcortical brain volumes 
segmentation. 
The figure shows the FreeSurfer 
segmentation results from the average 
brain template provided by the 
software (fsaverage). The three-
dimensional representation illustrates 
the shape, extension, and relative 
position within the brain of the 
different neuroanatomical structures 
in the present study. A. Anterior view. 
B. Posterior angle view. Cerebellar 
cortex, grey; hippocampus, red; 
amygdala, pink; putamen, orange; 
globus pallidum, blue; thalamus, 
purple; caudate, yellow; the lateral and 
inferior lateral ventricles, transparent 
grey. 
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Figure 2 
Relationships in the combined sample.  
 
 
Scatter plots showing significant relationships between subcortical volumes (μl) and 
neurocognitive performance, adjusted for age and ICV, in the combined sample. A) Larger 
left inferior lateral ventricle related to poorer motor speed performance (B = 0.21, p = 
0.00003), B) larger right hippocampus related to poorer working memory performance (B = 
-0.13, p = 0.0009), C) and D) left (B = -0.11, p = 0.004) and right putamen (r = -0.11, p = 
0.002) related  to poorer verbal learning. CVLT; California Verbal Learning Test. 
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